Page last updated: 2024-12-11

tetrodotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetrodotoxin: An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tetrodotoxin : A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11174599
CHEMBL ID507974
SCHEMBL ID6406675
MeSH IDM0021255
PubMed CID6324668
CHEMBL ID4208190
CHEBI ID9506
MeSH IDM0021255

Synonyms (56)

Synonym
tarichatoxin
spheroidine
maculotoxin
5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-, (4r-(4alpha,4aalpha,5alpha,7alpha,9alpha,10alpha,10abeta,11s*,12s*))-
bjt 1
brn 0049176
(4r-(4alpha,4aalpha,5alpha,7alpha,9alpha,10alpha,10abeta,11s*,12s*))-octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d) pyrimidine-4,7,10,11,12-pentol
5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-
babylonia japonica toxin 1
octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol
tetrodotoxine
hsdb 3543
tetradotoxin
fugu toxin
tetrodoxin
einecs 224-458-8
toxin, fugu
CHEMBL507974 ,
pft-1 toxin
tettrodotoxin
tectin
10-hydroxymethyl-5-imino-(2s)-12,13-dioxa-4,6-diazatetracyclo[7.3.1.13,11.03,8]tetradecane-1,2,7,10,14-pentaol
bdbm50344821
10-hydroxymethyl-5-imino-(2s)-12,13-dioxa-4,6-diazatetracyclo[7.3.1.13,11.03,8]tetradecane-1,2,7,10,14-pentaolcitrate
5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-, (4r,4ar,5r,7s,9s,10s,10ar,11s,12s)-
3kum2721u9 ,
ccris 9328
4-27-00-08206 (beilstein handbook reference)
unii-3kum2721u9
SCHEMBL6406675
Q-100286
tetrodotoxin [who-dd]
tetrodotoxin [mi]
tetrodotoxin [inn]
5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, 2-amino-1,4,4a,5,9,10-hexahydro-12-(hydroxymethyl)-, (4r,4ar,5r,7s,9s,10s,10ar,11s,12s)-
DTXSID10881342 ,
9sr ,
(1r,5r,6r,7r,9s,11s,12s,13s,14s)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name)
tetrodotoxina
bjt-1
tetrodotoxinum
(1r,5r,6r,7r,9s,11r,12r,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo(7.3.1.1(7,11).0(1,6))tetradecane-5,9,12,13,14-pentol
5,9:7,10a-dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-, (4r-(4alpha,4aalpha,5alpha,7alpha,9alpha, 10alpha,10abeta,11s*,12s*))-
dtxcid101022591
(4r,4ar,5r,7s,9s,10s,10ar,11s,12s)-2-amino-1,4,4a,5,9,10-hexahydro-12-(hydroxymethyl)-5,9:7,10a-dimethano-10ah-
gtpl2616
(1r,5r,6r,7r,9s,11r,12r,13s,14s)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol
tetrodontoxin
octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10ah-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol
fugu poison
CHEBI:9506 ,
ttx ,
tetrodotoxin
tetrotodoxin
CHEMBL4208190 ,
bdbm50466963

Research Excerpts

Overview

Tetrodotoxin (TTX) is a potent neurotoxin found in many marine and terrestrial animals, but only a few species. Tetrodotoxins are a group of potent neurotoxins named after the Tetraodontidae fish family (pufferfish)

ExcerptReferenceRelevance
"Tetrodotoxin (TTX) is a potent neurotoxin found in many marine and terrestrial animals, but only a few species, such as the ribbon worms of the genus "( Intrabody Tetrodotoxin Distribution and Possible Hypothesis for Its Migration in Ribbon Worms
Chernyshev, AV; Magarlamov, TY; Malykin, GV, 2021
)
2.47
"Tetrodotoxins (TTXs) are a group of potent neurotoxins named after the Tetraodontidae fish family (pufferfish). "( Tetrodotoxin in live bivalve mollusks from Europe: Is it to be considered an emerging concern for food safety?
Antonelli, P; Arcangeli, G; Barco, L; Bordin, P; Losasso, C; Orsini, M; Peruzzo, A; Salerno, B, 2022
)
3.61
"Tetrodotoxin (TTX) is a crystalline, weakly basic, colorless organic substance and is one of the most potent marine toxins known. "( An Updated Review of Tetrodotoxin and Its Peculiarities.
Campàs, M; Gokbulut, C; Katikou, P; Kosker, AR; Ozogul, F, 2022
)
2.48
"Tetrodotoxin (TTX) is a potent marine neurotoxin that exists in a variety of aquatic and terrestrial organisms. "( Transcriptomic analysis reveals the genes involved in tetrodotoxin (TTX) accumulation, translocation, and detoxification in the pufferfish Takifugu rubripes.
Hou, J; Li, P; Liu, X; Ren, J; Si, F; Sun, Z; Wu, B; Xu, J; Zhang, H; Zhu, Y, 2022
)
2.41
"Tetrodotoxin (TTX) is a neurotoxic natural product that is an indispensable probe in neuroscience, a biosynthetic and ecological enigma, and a celebrated target of synthetic chemistry. "( A concise synthesis of tetrodotoxin.
Ando, H; Hetzler, BE; Houk, KN; Konrad, DB; Matsuura, BS; Rühmann, KP; Strassner, N; Trauner, D, 2022
)
2.47
"Tetrodotoxin (TTX) is a deadly neurotoxin and usually accumulates in large amounts in the ovaries but is non-toxic or low toxic in the testis of pufferfish. "( Transcriptome analysis revealed gene expression feminization of testis after exogenous tetrodotoxin administration in pufferfish Takifugu flavidus.
Bao, B; Gong, X; He, X; Wu, H; Ye, Y, 2022
)
2.39
"Tetrodotoxin (TTX) is a potent neurotoxin responsible for a human intoxication event in Spain associated with the consumption of trumpet shell "( Tissue accumulation of tetrodotoxin (TTX) and analogues in trumpet shell
Afonso, II; Canário, AVM; Da Silva, JP; Lage, S; Reis Costa, P, 2023
)
2.66
"Tetrodotoxin (TTX) is a potent marine neurotoxin that occurs in several Australian phyla, including pufferfish, toadfish, gobies, and the blue-ringed octopus. "( Structural Characterization and Spatial Mapping of Tetrodotoxins in Australian Polyclads.
Briggs, MT; Hoffmann, P; Karuso, P; McNab, JM; Rodriguez, J; Williamson, JE, 2022
)
2.42
"Tetrodotoxin (TTX) is a kind of low-molecular-weight non-protein neurotoxin. "( Development of a Proton-Enhanced ESI UPLC-MS/MS Method for the Determination of Tetrodotoxin.
Li, T; Wang, P; Wang, R, 2022
)
2.39
"Tetrodotoxin (TTX) is a highly fatal marine biotoxin. "( Acute Toxic Effects of Tetrodotoxin in Mice via Intramuscular Injection and Oral Gavage.
Huang, Y; Li, J; Song, J; Wang, F; Wang, Q; Zhang, F; Zhang, L; Zou, S, 2023
)
2.66
"Tetrodotoxin (TTX) is an exceedingly toxic non-protein biotoxin that demonstrates remarkable selectivity and affinity for sodium channels on the excitation membrane of nerves. "( Transcriptomic Profiling of Tetrodotoxin-Induced Neurotoxicity in Human Cerebral Organoids.
Chen, X; Li, L; Liu, Z; Shi, J; Shi, T; Wang, Z; Wei, Y, 2023
)
2.65
"Tetrodotoxin (TTX) is a potent neurotoxin responsible for countless human intoxications and deaths around the world. "( Tetrodotoxin in marine bivalves and edible gastropods: A mini-review.
Biessy, L; Boundy, MJ; Harwood, DT; Hawes, I; Smith, KF; Wood, SA, 2019
)
3.4
"Tetrodotoxin (TTX) is a potent neurotoxin frequently occurring in marine organisms along with its numerous analogues. "( Development of a polyclonal antibody-based indirect competitive ELISA for the determination of tetrodotoxins in marine ribbon worms (NEMERTEA) and its comparison with high performance liquid chromatography-tandem mass spectrometry.
Kuznetsov, VG; Magarlamov, TY; Petrova, IY; Vlasenko, AE, 2020
)
2.22
"Tetrodotoxin (TTX) is a potent neurotoxin responsible for many food poisoning incidents and some fatalities. "( A fast magnetic bead-based colorimetric immunoassay for the detection of tetrodotoxins in shellfish.
Campàs, M; Campbell, K; Diogène, J; Gerssen, A; Rambla-Alegre, M; Reverté, J, 2020
)
2.23
"Tetrodotoxin (TTX) is a potent natural toxin causative of human food intoxications that shares its mechanism of action with the paralytic shellfish toxin saxitoxin (STX). "( Oral Chronic Toxicity of the Safe Tetrodotoxin Dose Proposed by the European Food Safety Authority and Its Additive Effect with Saxitoxin.
Boente-Juncal, A; Botana, LM; Camiña, M; Otero, P; Rodríguez, I; Rodriguez-Vieytes, M; Vale, C, 2020
)
2.28
"Tetrodotoxin (TTX) is a potent neurotoxin isolated mainly from toxic puffer fish. "( Puffer Fish Gut Microbiota Studies Revealed Unique Bacterial Co-Occurrence Patterns and New Insights on Tetrodotoxin Producers.
Cai, Z; Lai, Y; Lee, CH; Li, Z; Tian, J; Yu, CF, 2020
)
2.22
"Tetrodotoxin (TTX) is a highly specific voltage-gated sodium channel (VGSC) blocker in clinical evaluation as a peripheral-acting analgesic for chronic pain. "( Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy Adults.
Chai, P; Engel, C; Gallen, CC; Kavoosi, M; Korz, W; Lester, RM; O'Reilly, TE, 2020
)
2.23
"Tetrodotoxin (TTX) is a heat-stable neurotoxin typically associated with pufferfish intoxications. "( Survey of Tetrodotoxin in New Zealand Bivalve Molluscan Shellfish over a 16-Month Period.
Biessy, L; Boundy, MJ; Harwood, DT; Nicolas, J; Roughan, B, 2020
)
2.4
"Tetrodotoxin is a water-soluble toxin and cannot be directly ingested by shellfish."( A Microencapsulation Method for Delivering Tetrodotoxin to Bivalves to Investigate Uptake and Accumulation.
Biessy, L; Bowater, JRD; Hawes, I; Smith, KF; Tidy, A; van Ginkel, R; Wood, SA, 2021
)
1.61
"Tetrodotoxin (TTX) is a potent sodium channel blocker, with significant neurotoxicity, found in marine animals like pufferfish and blue-ringed octopus. "( A cluster of tetrodotoxin poisoning in Oman.
Al Lawatia, S; Al-Abri, S; Alhatali, B; Coleman, RM; Hamelin, EI; Johnson, R; Kantur, S; Kapil, V; Kazzi, Z; Khamis, F; Thomas, J, 2022
)
2.53
"Tetrodotoxin (TTX) is a potent neurotoxin found mainly in puffer fish and other marine and terrestrial animals. "( Tetrodotoxin, a Potential Drug for Neuropathic and Cancer Pain Relief?
Gómez-Navas, C; González-Cano, R; Nieto, FR; Ruiz-Cantero, MC; Santos-Caballero, M; Tejada, MÁ, 2021
)
3.51
"Tetrodotoxin (TTX) is a potent neurotoxin that was first identified in pufferfish but has since been isolated from an array of taxa that host TTX-producing bacteria. "( From Poison to Promise: The Evolution of Tetrodotoxin and Its Potential as a Therapeutic.
Bucciarelli, GM; Eisthen, HL; Fontes, A; Kats, LB; Lechner, M; Shaffer, HB, 2021
)
2.33
"Tetrodotoxin (TTX) is a powerful sodium channel blocker that in low doses can safely relieve severe pain. "( A Study of 11-[³H]-Tetrodotoxin Absorption, Distribution, Metabolism and Excretion (ADME) in Adult Sprague-Dawley Rats.
Bai, K; Chen, H; Dong, Y; Han, J; He, J; Hong, B; Xie, Q; Yi, R, 2017
)
2.23
"Tetrodotoxin (TTX) is a potent neurotoxin that exerts analgesic actions in both humans and rodents under different somatic pain conditions, but its effect has been unexplored in visceral pain."( Effects of Tetrodotoxin in Mouse Models of Visceral Pain.
Artacho-Cordón, A; Cendán, CM; Entrena, JM; González-Cano, R; Nieto, FR; Tejada, MÁ; Wood, JN, 2017
)
1.57
"Tetrodotoxin (TTX) is a potent neurotoxin naturally found in terrestrial and marine animals targeting the voltage-gated sodium channels. "( An in silico perspective on the toxicodynamic of tetrodotoxin and analogues - A tool for supporting the hazard identification.
Dall'Asta, C; Dellafiora, L; Galaverna, G, 2017
)
2.15
"Tetrodotoxin (TTX) is a key chemical defense trait in North American and Eurasian newts (Salamandridae)."( An amphibian chemical defense phenotype is inducible across life history stages.
Bucciarelli, GM; Green, DB; Kats, LB; Shaffer, HB, 2017
)
1.18
"Tetrodotoxin (TTX) is a potent, low molecular weight analyte that can lead to fatal poisoning and requires a sensitive, rapid detection method. "( A new lateral-flow immunochromatographic strip combined with quantum dot nanobeads and gold nanoflowers for rapid detection of tetrodotoxin.
Cheng, Z; Fu, Q; Huang, C; Shen, H; Tang, Y; Xiao, M; Xu, F; Zhang, S, 2017
)
2.1
"Tetrodotoxin (TTX, 1) is a potent neurotoxin that is widely found in both terrestrial and marine animals; however, the biosynthetic pathway and genes for TTX have not yet been elucidated. "( Spiro Bicyclic Guanidino Compounds from Pufferfish: Possible Biosynthetic Intermediates of Tetrodotoxin in Marine Environments.
Cho, Y; Konoki, K; Kudo, Y; Nishikawa, T; Onodera, KI; Sugimoto, K; Ueyama, N; Yotsu-Yamashita, M, 2018
)
2.14
"Tetrodotoxin (TTX) is a potent neurotoxin associated with human poisonings through the consumption of pufferfish. "( The Acute Toxicity of Tetrodotoxin and Tetrodotoxin⁻Saxitoxin Mixtures to Mice by Various Routes of Administration.
Boundy, MJ; Finch, SC; Harwood, DT, 2018
)
2.24
"Tetrodotoxin is a potent non-proteinaceous neurotoxin, which is commonly found in the marine environment. "( The evolution and origin of tetrodotoxin acquisition in the blue-ringed octopus (genus Hapalochlaena).
Cooke, IR; Finn, J; Strugnell, JM; Whitelaw, BL; Zenger, K, 2019
)
2.25
"Tetrodotoxin (TTX) is a potent marine neurotoxin with bacterial origin. "( The Incidence of Tetrodotoxin and Its Analogs in the Indian Ocean and the Red Sea.
Silva, M; Tamele, IJ; Vasconcelos, V, 2019
)
2.3
"Tetrodotoxin (TTX) is a neurotoxin mainly responsible for severe neurological illness, and okadaic acid (OA) is another important lipophilic toxin to humans. "( Detection of okadaic acid (OA) and tetrodotoxin (TTX) simultaneously in seafood samples using colloidal gold immunoassay.
Li, X; Ling, S; Wang, K; Wang, R; Wang, S; Xin, S; Yuan, J; Zhang, D; Zhao, Q; Zhao, W, 2019
)
2.23
"Tetrodotoxin (TTX) is an extremely toxic marine compound produced by different genera of bacteria that can reach humans through ingestion mainly of pufferfish but also of other contaminated fish species, marine gastropods or bivalves. "( Acute Toxicity Assessment: Macroscopic and Ultrastructural Effects in Mice Treated with Oral Tetrodotoxin.
Abal, P; Botana, LM; Louzao, MC; Vieytes, MR; Vilariño, N, 2019
)
2.18
"Tetrodotoxin (TTX) is a potent alkaloid typically from tropical ecosystems, but in the last decade its presence has been more pronounced in the temperate waters of the Atlantic. "( Tetrodotoxins Occurrence in Non-Traditional Vectors of the North Atlantic Waters (Portuguese Maritime Territory, and Morocco Coast).
Alfonso, A; Barreiro, A; Botana, LM; Hassouani, M; Kaufmann, M; Neto, AI; Rodríguez, I; Sabour, B; Silva, M; Vasconcelos, V, 2019
)
3.4
"Tetrodotoxin (TTX) is a potent neurotoxin that is receiving increasing interest in the European Union because it has been found in different fishery products (fish, bivalves and gastropods) captured in European waters. "( Occurrence of Tetrodotoxin in Bivalves and Gastropods from Harvesting Areas and Other Natural Spaces in Spain.
Blanco, L; Cabado, AG; González, V; Lago, J; Paz, B; Rambla-Alegre, M, 2019
)
2.32
"Tetrodotoxin (TTX) is a potent neurotoxin emerging in European waters due to increasing ocean temperatures. "( Development and single laboratory validation of an optical biosensor assay for tetrodotoxin detection as a tool to combat emerging risks in European seafood.
Barnes, P; Campbell, K; Elliott, CT; Haughey, SA; Higgins, C; Kawatsu, K; Vasconcelos, V, 2013
)
2.06
"Tetrodotoxin (TTX) is a neurotoxin that has been reported from taxonomically diverse organisms across 14 different phyla. "( Diversity and biosynthetic potential of culturable microbes associated with toxic marine animals.
Chau, R; Kalaitzis, JA; Neilan, BA; Wood, SA, 2013
)
1.83
"Tetrodotoxin (TTX), is a potent neurotoxin found in genetically diversed organisms. "( Microbial diversity associated with tetrodotoxin production in marine organisms.
Pratheepa, V; Vasconcelos, V, 2013
)
2.11
"Tetrodotoxin is a potent blocker of the skeletal muscle sodium-channel isoform Na(v)1.4 (IC50 10 nM), but micromolar concentrations of tetrodotoxin are required to inhibit the primary cardiac isoform Na(v)1.5."( Antagonistic effects of tetrodotoxin on aconitine-induced cardiac toxicity.
Hayakawa, H; Hayashida, M; Ohno, Y; Ono, T; Tezuka, A, 2013
)
1.42
"Tetrodotoxin (TTX) is a potent toxin but it could be used in pharmaceutical field. "( Detection of tetrodotoxin-producing Providencia rettgeri T892 in Lagocephalus pufferfish.
Hieu, D; Romero-Jovel, S; Tu, N; Tu, Q; Tung, H, 2014
)
2.21
"Tetrodotoxin (TTX) is a naturally occurring toxin that has been responsible for human intoxications and fatalities. "( Tetrodotoxin: chemistry, toxicity, source, distribution and detection.
Bane, V; Dikshit, M; Furey, A; Lehane, M; O'Riordan, A, 2014
)
3.29
"Tetrodotoxin (TTX) is a small molecular weight neurotoxin that occludes voltage-gated sodium channels in nerve and muscle tissue, resulting in respiratory paralysis and death. "( Construction of a single chain variable fragment antibody (scFv) against tetrodotoxin (TTX) and its interaction with TTX.
Huang, A; Li, X; Ling, S; Liu, L; Lu, T; Wang, L; Wang, R; Wang, S; Xiang, S, 2014
)
2.08
"Tetrodotoxin is a low molecular weight compound that acts by blocking voltage-gated sodium channels, inducing paralysis."( Confirmation and distribution of tetrodotoxin for the first time in terrestrial invertebrates: two terrestrial flatworm species (Bipalium adventitium and Bipalium kewense).
Brodie, ED; Ducey, PK; French, SS; Hanifin, CT; Neuman-Lee, L; Pfrender, ME; Stokes, AN, 2014
)
1.41
"Tetrodotoxin is an enigmatic neurotoxin that is found in a wide-variety of organisms. "( Tetrodotoxin concentrations within a clutch and across embryonic development in eggs of the rough-skinned newts (Taricha granulosa).
Brodie, ED; French, SS; Gall, BG; Pett, JJ; Spivey, KL; Stokes, AN, 2014
)
3.29
"Tetrodotoxin is a deadly, potent poison; the minimum lethal dose in an adult human is estimated to be 2-3 mg."( Tetrodotoxin poisoning outbreak from imported dried puffer fish--Minneapolis, Minnesota, 2014.
Cole, JB; Deeds, JR; Handy, SM; Heegaard, WG; McGrath, SC, 2015
)
2.58
"Tetrodotoxin (TTX) is a potent neurotoxin found in the tissues of many taxonomically diverse organisms. "( No evidence for a culturable bacterial tetrodotoxin producer in Pleurobranchaea maculata (Gastropoda: Pleurobranchidae) and Stylochoplana sp. (Platyhelminthes: Polycladida).
Cary, SC; McNabb, P; Salvitti, LR; Wood, SA, 2015
)
2.13
"Tetrodotoxin (TTX), is a potent neurotoxin targeting sodium channels that has been identified in multiple marine and terrestrial organisms. "( Intracellular immunohistochemical detection of tetrodotoxin in Pleurobranchaea maculata (Gastropoda) and Stylochoplana sp. (Turbellaria).
Cary, SC; Salvitti, LR; Winsor, L; Wood, SA, 2015
)
2.12
"Tetrodotoxin (TTX) is a potent neurotoxin found in a number of marine creatures including the pufferfish, where it is synthesized by bacteria and accumulated through the food chain. "( Selective blocking effects of 4,9-anhydrotetrodotoxin, purified from a crude mixture of tetrodotoxin analogues, on NaV1.6 channels and its chemical aspects.
Teramoto, N; Yotsu-Yamashita, M, 2015
)
2.13
"Tetrodotoxin (TTX) is a deadly neurotoxin which selectively inhibits Na(+) activation mechanism of nerve impulse, without affecting the permeability of K(+) ions. "( An overview on the origin and production of tetrodotoxin, a potent neurotoxin.
Jal, S; Khora, SS, 2015
)
2.12
"Tetrodotoxin is a marine biotoxin with high acute toxicity. "( Study of the matrix effects of tetrodotoxin and its content in cooked seafood by liquid chromatography with triple quadrupole mass spectrometry.
Huang, BF; Lu, M; Ren, YP; Xu, XM; Yu, XW, 2015
)
2.15
"Tetrodotoxin (TTX) is a selective voltage-gated sodium channel blocker currently in clinical trials as an analgesic."( Tetrodotoxin suppresses thermal hyperalgesia and mechanical allodynia in a rat full thickness thermal injury pain model.
Clifford, JL; Korz, W; McIntyre, MK; Petz, LN; Salas, MM; Wong, D, 2015
)
2.58
"Tetrodotoxin (TTX) is a potent neurotoxin responsible for many human intoxications and fatalities each year. "( Tetrodotoxin, an Extremely Potent Marine Neurotoxin: Distribution, Toxicity, Origin and Therapeutical Uses.
Blanco, L; Cabado, AG; Lago, J; Rodríguez, LP; Vieites, JM, 2015
)
3.3
"Tetrodotoxin is a neurotoxin responsible for many human fatalities, most commonly following the consumption of pufferfish. "( Potential Threats Posed by Tetrodotoxins in UK Waters: Examination of Detection Methodology Used in Their Control.
Higgins, C; Higman, W; Hungerford, J; Turner, AD, 2015
)
2.16
"Tetrodotoxin is a naturally occurring toxin that is used as an antipredator defense in the rough-skinned newt (Taricha granulosa)."( Comparing the Natural and Anthropogenic Sodium Channel Blockers Tetrodotoxin and Indoxacarb in Garter Snakes.
Brodie, ED; French, SS; Hansen, T; Neuman-Lee, LA, 2016
)
1.39
"Tetrodotoxin (TTX) is an extremely potent paralytic toxin responsible for yearly illness and death around the world. "( Development and validation of a high-throughput online solid phase extraction - Liquid chromatography - Tandem mass spectrometry method for the detection of tetrodotoxin in human urine.
Bragg, W; Coleman, R; Garrett, A; Hamelin, E; Johnson, RC; Lemire, SW; Ojeda-Torres, G; Thomas, J, 2016
)
2.07
"Tetrodotoxin (TTX) is an emerging toxin in the European marine environment. "( High-resolution mass spectrometry analysis of tetrodotoxin (TTX) and its analogues in puffer fish and shellfish.
Bane, V; Barnes, P; Brosnan, B; Furey, A; Lehane, M, 2016
)
2.14
"Tetrodotoxin (TTX) is a potent toxin that specifically binds to voltage gated sodium channels. "( Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin.
Lee, CH; Ruben, PC,
)
1.81
"Tetrodotoxin (TTX) is a neurotoxin found in puffer fish and other marine animals. "( Tetrodotoxin reduces cue-induced drug craving and anxiety in abstinent heroin addicts.
Epstein, DH; Liu, TT; Lu, L; Shi, J; Wang, X; Zhang, XL; Zhao, LY, 2009
)
3.24
"Tetrodotoxin is a neurotoxin that occurs in select species of the family Tetraodontidae (puffer fish). "( Public health response to puffer fish (Tetrodotoxin) poisoning from mislabeled product.
Austin, C; Cohen, NJ; Deeds, JR; Dizikes, G; Gerber, SI; Guichard, FM; Hanner, RH; Huh, I; Pham, TD; Thompson, TM; Wahl, M; White, KD; Wong, ES; Yancy, HF, 2009
)
2.06
"Tetrodotoxin (TTX) is a potent blocker of voltage-gated sodium channels, but not all sodium channels are equally sensitive to inhibition by TTX. "( Functional expression of an arachnid sodium channel reveals residues responsible for tetrodotoxin resistance in invertebrate sodium channels.
Dong, K; Du, Y; Huang, ZY; Liu, Z; Nomura, Y, 2009
)
2.02
"Tetrodotoxin (TTX) is a low molecular weight (approximately 319 Da) neurotoxin found in a number of animal species, including pufferfish. "( Fluidic force discrimination assays: a new technology for tetrodotoxin detection.
Etheridge, SM; Mulvaney, SP; Tamanaha, CR; Yakes, BJ, 2010
)
2.05
"Tetrodotoxin (TTX) is a potent toxin that specifically binds to voltage-gated sodium channels (NaV). "( Biophysical costs associated with tetrodotoxin resistance in the sodium channel pore of the garter snake, Thamnophis sirtalis.
Ahern, C; Jones, DK; Lee, CH; Ruben, PC; Sarhan, MF, 2011
)
2.09
"Tetrodotoxin (TTX) is a low molecular weight neurotoxin found in a number of animal species, including pufferfish. "( Evaluation of surface plasmon resonance biosensors for detection of tetrodotoxin in food matrices and comparison to analytical methods.
Deeds, J; Degrasse, SL; White, K; Yakes, BJ, 2011
)
2.05
"1 Tetrodotoxin (TTX) is a useful pharmacological tool for distinguishing neural and myogenic responses of isolated visceral organs to drugs. "( Colon-specific contractile responses to tetrodotoxin in the isolated mouse gastrointestinal tract.
Kitazawa, T; Kondo, T; Okuno, Y; Saeki, A; Teraoka, H; Uchida, E,
)
1.12
"1. Tetrodotoxin (TTX) is a powerful sodium channel blocker extracted from the puffer fish. "( Tetrodotoxin alleviates acute heroin withdrawal syndrome: a multicentre, randomized, double-blind, placebo-controlled study.
Kang, L; Li, J; Lu, CL; Song, H; Xie, L; Zhang, YY; Zhong, S; Zhou, XB, 2011
)
2.43
"Tetrodotoxin (TTX) is a heterocyclic guanidinium alkaloid (C11H17N3O8) with molecular mass of ∼320 Da. "( Human ScFv that block sodium ion channel activity of tetrodotoxin.
Bangphoomi, K; Chaicumpa, W; Choowongkomon, K; Chulanetra, M; Sakolvarvaree, Y; Sookrung, N; Srimanote, P; Thanongsaksrikul, J, 2012
)
2.07
"Tetrodotoxin (TTX) is a powerful sodium channel blocker found in puffer fish and some marine animals. "( Analytical challenges: determination of tetrodotoxin in human urine and plasma by LC-MS/MS.
Fong, BM; Leung, KS; Tsoi, YK, 2011
)
2.08
"Tetrodotoxin (TTX) is a potent neurotoxin that has been identified in a range of phylogenetically unrelated marine and terrestrial organisms. "( Tetrodotoxin concentrations in Pleurobranchaea maculata: temporal, spatial and individual variability from New Zealand populations.
Adamson, J; Cary, SC; McNabb, P; Taylor, DI; Walker, J; Wood, SA, 2012
)
3.26
"Tetrodotoxin (TTX) is a potent neurotoxin that blocks voltage-gated sodium channels (VGSCs). "( Tetrodotoxin (TTX) as a therapeutic agent for pain.
Cendán, CM; Cobos, EJ; González-Cano, R; Nieto, FR; Sánchez-Fernández, C; Tejada, MÁ, 2012
)
3.26
"Tetrodotoxin is a potent low weight marine toxin found in warm waters, especially of the Indian and Pacific Oceans. "( New gastropod vectors and tetrodotoxin potential expansion in temperate waters of the Atlantic Ocean.
Alfonso, A; Azevedo, J; Botana, LM; Rodriguez, P; Silva, M; Vasconcelos, V, 2012
)
2.12
"Tetrodotoxin (TTX) is a potent neurotoxin which is known to occur in numerous taxa, including newts. "( No evidence for an endosymbiotic bacterial origin of tetrodotoxin in the newt Taricha granulosa.
Brodie, ED; Lehman, EM, 2004
)
2.02
"Tetrodotoxin (TTX) is a selective blocker of voltage-gated Na+ channels that is used to block action potentials in vitro and in vivo. "( A microcapsule technique for long-term conduction block of the sciatic nerve by tetrodotoxin.
Martinov, VN; Njå, A, 2005
)
2
"Tetrodotoxin (TTX) is a sodium channel blocker that temporarily inactivates both neurons and fibers of passage and thus may be functionally equivalent to an electrolytic lesion, but without allowing time for neural adaptation."( Tetrodotoxin inactivation of pontine regions: influence on sleep-wake states.
Morrison, AR; Ross, RJ; Sanford, LD; Tang, X; Yang, L, 2005
)
2.49
"Tetrodotoxin (TTX) is a high toxic small molecular neurotoxin. "( Immunologic protection of anti-tetrodotoxin vaccines against lethal activities of oral tetrodotoxin challenge in mice.
Rong, KT; Wei, CH; Xu, QH; Zhao, XN, 2005
)
2.06
"Tetrodotoxin (TTX) is a highly potent neurotoxin that selectively binds to the outer vestibule of voltage-gated sodium channels. "( Genetic basis of tetrodotoxin resistance in pufferfishes.
Brenner, S; Dandona, N; Lu, SQ; See, SL; Soong, TW; Venkatesh, B, 2005
)
2.11
"Tetrodotoxin (TTX) is a powerful sodium channel blocker extracted from the puffer fish. "( Antinociceptive effects of tetrodotoxin (TTX) in rodents.
Beaulieu, P; Guindon, J; Lu, S; Marcil, J; Ngoc, AH; Walczak, JS, 2006
)
2.07
"Tetrodotoxin (TTX) is a haptenic, highly toxic neurotoxin with no specific antidote available yet. "( Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine.
Cheng, JP; Rong, KT; Wei, CH; Xu, QH; Zhang, QH; Zhao, XN,
)
1.8
"Tetrodotoxin (TTN) is a marine neurotoxin that is sometimes responsible for the mortality of pufferfish consumers. "( Electrophysiological studies on acute tetrodotoxin poisoning: a case report.
Chow, SY; Fong, VH, 1996
)
2.01
"Tetrodotoxin is a long-acting topical anesthetic in the rabbit cornea. "( Experimental study of tetrodotoxin, a long-acting topical anesthetic.
Duncan, JL; Duncan, KG; Fields, HL; Jones, MR; Schwartz, DM, 1998
)
2.06
"Tetrodotoxin (TTX) is a potent marine neurotoxin named after the order of fish from which it is most commonly associated, the Tetraodontiforms, or the tetraodon pufferfish. "( Effect of tetrodotoxin (TTX) on some brain neurotransmitters in rats.
Ahmed, SM; Mady, EA; Youssef, NM; Zaki, ZA, 2001
)
2.16
"Tetrodotoxin is a noncompetitive inhibitor of activation by each of these toxins (KI = 4-8 nM)."( Cooperative activation of action potential Na+ ionophore by neurotoxins.
Catterall, WA, 1975
)
0.98

Effects

Tetrodotoxin (TTX) has been used to determine the roles of several brain areas in diverse physiological processes. It transiently inhibits the sodium-dependent action potentials, thus blocking all neural activity in the target region. It has emerged as a potentially efficacious agent for chemotherapy-induced neuropathic pain.

ExcerptReferenceRelevance
"Tetrodotoxin has a slight inhibitory effect additional to that extended by Mg2+ during the initial phase of uptake into high potassium stimulated synaptosomes."( Uptake of radiocalcium by nerve endings isolated from rat brain: kinetic studies.
Gripenberg, J; Heinonen, E; Jansson, SE, 1980
)
0.98
"Tetrodotoxin (TTX) has shown analgesia in preclinical models and clinical trials, but its clinical efficacy and safety have not been quantified."( Efficacy and Security of Tetrodotoxin in the Treatment of Cancer-Related Pain: Systematic Review and Meta-Analysis.
Artacho-Cordón, A; de la Nava, J; Huerta, MÁ; Nieto, FR, 2023
)
1.93
"Tetrodotoxin has been used to determine the roles of several brain areas in diverse physiological processes because it transiently inhibits the sodium-dependent action potentials, thus blocking all neural activity in the target region."( Unraveling the Role of Discrete Areas of the Rat Brain in the Regulation of Ovulation through Reversible Inactivation by Tetrodotoxin Microinjections.
Arrieta-Cruz, I; Bolaños-Hurtado, M; Cruz, ME; Domínguez, R; Flores, A; Juárez-Tapia, C; Silva, CC, 2020
)
1.49
"Tetrodotoxin (TTX) has emerged as a potentially efficacious agent for chemotherapy-induced neuropathic pain (CINP), a prevalent, debilitating condition often resistant to analgesics. "( Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial.
Deck, K; Goldlust, SA; Kavoosi, M; Korz, W; Nezzer, J, 2021
)
3.51
"Tetrodotoxin (TTX) has been believed for a long time to be a selective inhibitor of voltage-gated fast Na(+) channels in excitable tissues, including mammalian myocardium. "( Tetrodotoxin blocks native cardiac L-type calcium channels but not CaV1.2 channels expressed in HEK cells.
Bartok, A; Hegyi, B; Krasznai, Z; Nanasi, PP; Papp, F; Szentandrassy, N, 2013
)
3.28
"Tetrodotoxin (TTX) has been used for many decades to characterize the structure and function of biological ion channels. "( Mechanism of tetrodotoxin block and resistance in sodium channels.
Chen, R; Chung, SH, 2014
)
2.21
"Tetrodotoxin (TTX) has been identified from taxonomically diverse organisms. "( Production level of tetrodotoxin in Aeromonas is associated with the copy number of a plasmid.
Bao, B; Gong, X; Liu, J; Lu, Y; Ma, T; Wei, F; Zhao, J, 2015
)
2.18
"Tetrodotoxin (TTX) has been usually analyzed in marine and other sources by HPLC separation, followed by alkaline treatment and fluorescence assay. "( Identification and quantification of tetrodotoxin in the marine gastropod Nassarius by LC-MS.
Huang, HN; Lin, HL; Lin, J, 2008
)
2.06
"Tetrodotoxin (TTX) has no effect on 22Na uptake stimulated by carbachol, whereas methoxyverapamil (D 600) produces a small but significant decrease in both 22Na and 45Ca uptake."( Stimulus-permeability coupling in rat lacrimal gland.
Parod, RJ; Putney, JW, 1980
)
0.98
"Tetrodotoxin has minimal effects on passive permeabilities but reduce the Hill coefficient n for P(Na) but not P(Cl), while procaine reduces n for both P(Na) and P(Cl)."( Control of ionic permeability by membrane charged groups: dependency on pH, depolarization, tetrodotoxin and procaine.
Strickholm, A, 1981
)
1.2
"Tetrodotoxin has a slight inhibitory effect additional to that extended by Mg2+ during the initial phase of uptake into high potassium stimulated synaptosomes."( Uptake of radiocalcium by nerve endings isolated from rat brain: kinetic studies.
Gripenberg, J; Heinonen, E; Jansson, SE, 1980
)
0.98
"1. Tetrodotoxin (TTX) has been widely used as a chemical tool for blocking Na+ channels. "( Tetrodotoxin-resistant sodium channels.
Yoshida, S, 1994
)
2.35
"Tetrodotoxin, that has been shown by other investigators to induce a release of thiamine from nerve membranes, does not alter the action of thiamine on the exponential decline of current and vice versa."( The action of thiamine and its di- and triphosphates on the slow exponential decline of the ionic currents in the node of Ranvier.
Duppel, W; Fox, JM, 1975
)
0.98
"Tetrodotoxin has been reported to cause prolonged systemic hypotension without resultant ischemic damage. "( Tetrodotoxin protects against acute ischemic renal failure in the rat.
Bergman, SM; Handa, RK; Holmes, RP; Li, WJ; McCullough, DL; Strandhoy, JW, 1992
)
3.17
"This tetrodotoxin receptor has been solubilized, and several parameters influencing the efficiency of this critical step have been studied."( Solubilization of sodium channel from human brain.
Bettendorff, L; de Rycker, C; Grandfils, C; Schoffeniels, E, 1989
)
0.73
"Tetrodotoxin (TTX) has been presented as an ultra-long-acting local anesthetic. "( [The local anesthetic effect of tetrodotoxin on the natural spike activity of the depressor nerve in rabbits].
Beyer, G; Lipfert, P; Lömm, M, 1989
)
2
"Tetrodotoxin has no accelerative effect on cerebral aerobic glycolysis."( Effects of tetrodotoxin and anaesthetics on brain metabolism and transport during anoxia.
Quastel, JH; Shankar, R, 1972
)
1.36

Actions

Tetrodotoxin was found to cause a dose-dependent reduction in the frequency at which Na+ channels conduct during a series of depolarizations. Tetrodot toxin did not inhibit the contractile response to nicotine in the dog bronchial preparation.

ExcerptReferenceRelevance
"Tetrodotoxin was used to inhibit the retinal neural activity for confirming the origin of TES-induced IOSs."( Depth-Resolved Physiological Response of Retina to Transcorneal Electrical Stimulation Measured With Optical Coherence Tomography.
Chai, X; Chen, J; Chen, Y; Di, L; Li, H; Li, Q; Su, X; Sun, P; Zheng, H; Zhou, C, 2019
)
1.24
"Tetrodotoxin (TTX) did not inhibit the effects of arecoline."( Arecoline excites the contraction of distal colonic smooth muscle strips in rats via the M3 receptor-extracellular Ca2+ influx - Ca2+ store release pathway.
Li, CB; Liu, CY; Tang, WB; Xie, DP; Yang, X, 2010
)
1.08
"Tetrodotoxin did not increase blood flow in the sciatic nerve."( Epinephrine prevents muscle blood flow increases after perineural injection of tetrodotoxin.
Berde, CB; Cairns, BE; Dunning, PS; Masuda, T; Sadhasivam, S, 2004
)
1.27
"Tetrodotoxin did not inhibit the nicotine-evoked tritium release from the bronchial preparation."( Tetrodotoxin-resistant response to nicotine in rabbit bronchial preparation.
Hiruta, T; Kizawa, Y; Takayanagi, I, 1984
)
2.43
"Tetrodotoxin blocked the increase in the release and synthesis of ACh induced by tityustoxin."( Effects of tityustoxin (TsTX) from scorpion venom on the release and synthesis of acetylcholine in brain slices.
Gomez, MV; Macedo, TM, 1982
)
0.99
"Tetrodotoxin failed to inhibit glucose-stimulated insulin release."( Regulation of calcium fluxes in rat pancreatic islets: dissimilar effects of glucose and of sodium ion accumulation.
Herchuelz, A; Malaisse, WJ, 1980
)
0.98
"Tetrodotoxin did not inhibit the chronotropic effect of neostigmine."( A comparison between chronotropic effects of neostigmine and edrophonium in isolated guinea pig right atrium.
Endou, M; Okumura, F; Tanito, Y, 1997
)
1.02
"Tetrodotoxin was found to cause a dose-dependent reduction in the frequency at which Na+ channels conduct during a series of depolarizations."( All or none block of single Na+ channels by tetrodotoxin.
Narahashi, T; Quandt, FN; Yeh, JZ, 1985
)
1.25
"4. Tetrodotoxin did not inhibit the contractile response to nicotine in the dog bronchial preparation, suggesting that the nicotine-induced response may be produced mainly through a sodium action potential-independent process."( Characterization of nicotine-induced contraction in the canine bronchus.
Furukawa, A; Kizawa, Y; Takayanagi, I; Toyoda, T, 1988
)
0.79
"Tetrodotoxin does not inhibit the effect of 5HT and 5HT's effect is additive with that of KCl and veratrine."( Biochemical characterization of serotonin stimulated phosphoinositide turnover.
Conn, PJ; Sanders-Bush, E, 1986
)
0.99

Treatment

Pretreatment with tetrodotoxin (0.3 microM; a Na+ channel blocker) or glycerol (a T tubule uncoupler) significantly reduced the triphenyltin-induced contracture. Pretreatment with Mg2+ or kynurenate did not affect the increase in BFcrb elicited by systemic hypercapnia.

ExcerptReferenceRelevance
"Tetrodotoxin (TTX) pretreatment significantly reduced responses to carbachol in FSL rats at all concentrations tested, though this was only seen with lower concentrations in FRL rats."( Phenotypic differences in cholinergic responses of distal colonic epithelium.
Hernandez, J; Prior, T; Rangachari, PK; Tougas, G, 2004
)
1.04
"When tetrodotoxin treatment was stopped after 11 weeks, columns subsequently formed in the next 3 weeks."( Tetrodotoxin blocks the formation of ocular dominance columns in goldfish.
Meyer, RL, 1982
)
2.16
"In tetrodotoxin (TTX) treatment conditions (n = 13), NMA elicited depolarization, an increase in apparent Rinp, and rhythmic membrane potential oscillations without action potential bursts (i.e., plateau potentials), suggesting that the effects of NMA observed in the TTX-free condition resulted from activation of postsynaptic NMDA receptors."( NMDA-induced burst discharge in guinea pig trigeminal motoneurons in vitro.
Chandler, SH; Kim, YI, 1995
)
0.81
"Tetrodotoxin treatment blocked the LHRH response to NPY by more than 50%.(ABSTRACT TRUNCATED AT 400 WORDS)"( Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
Besecke, LM; Levine, JE; Pierce, ME; Takahashi, JS; Wolfe, AM, 1994
)
1.01
"Tetrodotoxin pretreatment (10(-6) M) reduced basal VIP release by > 80% and abolished the VIP increase observed during anaphylaxis, without modifying TXB2 release or the bronchoconstrictor response."( Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
Ciabattoni, G; Currò, D; Montuschi, P; Preziosi, P; Togna, G, 1993
)
1.01
"Tetrodotoxin (TTX) treatment did not prevent the increase in AChE expression, whereas nifedipine partially blocked it."( Mechanical stimulation increases expression of acetylcholinesterase in cultured myotubes.
Hubatsch, DA; Jasmin, BJ, 1997
)
1.02
"On tetrodotoxin treatment, climbing fibers become atrophic and may sprout thin collateral ramifications directed mainly toward the granular layer."( Control of spine formation by electrical activity in the adult rat cerebellum.
Bravin, M; Morando, L; Rossi, F; Strata, P; Vercelli, A, 1999
)
0.82
"In tetrodotoxin-treated striatal slices, halothane and isoflurane significantly increased dopamine basal release (EC50 = 0.33 mM and 0.41 mM for halothane and isoflurane, respectively). "( Halothane and isoflurane increase spontaneous but reduce the N-methyl-D-aspartate-evoked dopamine release in rat striatal slices: evidence for direct presynaptic effects.
Desmonts, JM; Dupont, H; Henzel-Rouellé, D; Keita, H; Mantz, J, 1999
)
0.92
"In tetrodotoxin-treated muscles AcS produced marked potentiation of twitch tension and an appropriate shift in the tension-voltage relation."( Electromechanical studies on the inotropic effects of acetylstrophanthidin in ventricular muscle.
Greenspan, AM; Morad, M, 1975
)
0.77
"In tetrodotoxin treated fibers as depolarization of the fiber is increased contraction spreads from superficial to axial myofibrils."( Electrical properties of the transverse tubular system.
Costantin, LL, 1975
)
0.77
"In tetrodotoxin-treated cultures the number of surviving neurons decreased significantly between 1 and 2 weeks in vitro, to remain constant thereafter."( Chronic blockade of bioelectric activity in neonatal rat cortex grown in vitro: morphological effects.
Baker, RE; De Jong, BM; Romijn, HJ; Ruijter, JM, 1991
)
0.8
"Tetrodotoxin (TTX) treatment shows that neuronal activity plays a role in refinement of the retinal fibers."( Differentiation of avian retinotectal projection.
Ichijo, H; Kobayashi, T; Nakamura, H, 1990
)
1
"Tetrodotoxin-treatment reduced the amount of fucosyl glycoproteins, but not proline-labeled proteins, axonally transported to the lateral geniculate nucleus during the first three weeks of postnatal development."( The effect of intraocular injection of tetrodotoxin on fast axonal transport of [3H]proline- and [3H]fucose-labeled materials in the developing rat optic nerve.
Matthews, MA; Riccio, RV, 1985
)
1.26
"In tetrodotoxin (TTX)-treated preparations, quinidine caused significant prolongation of APD50 from 529 +/- 19 msec to 597 +/- 11 msec, (n = 9) and inhibition of twitch tension, but lidocaine did not affect APD50 and twitch tension."( Effects of quinidine and lidocaine on action potential and membrane currents of frog ventricles.
Morad, M; Su, MJ, 1987
)
0.79
"In tetrodotoxin-treated mucosa, isoproterenol increased 5-HT release to 28.6 +/- 5.3 ng/cm2/45 min which was significantly greater (P less than 0.05) than that with tetrodotoxin alone."( Beta-adrenoceptors on duodenal mucosal cells mediate venous serotonin release.
Borum, EH; Kellum, JM; Kuemmerle, JF; Smith, EH, 1988
)
0.79
"In tetrodotoxin-treated cultures, PHI-27 and GRF prevented the neuronal cell death produced by TTX, but only at concentrations greater than 0.1 microM."( Structural specificity of peptides influencing neuronal survival during development.
Brenneman, DE; Foster, GA,
)
0.65
"Both tetrodotoxin treatment and calcium omission from the medium prevented such an evoked-outflow of tritium."( Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.
Chiari, MC; D'Agostino, G; Grana, E; Kilbinger, H, 1986
)
0.73
"Pretreatment with tetrodotoxin reduced the increase in mucosal permeability in response to luminal hypotonicity."( Hypotonicity-Induced Increase in Duodenal Mucosal Permeability Is Regulated by Cholinergic Receptors in Rats.
Dahlgren, D; Nylander, O; Sjöblom, M, 2023
)
1.23
"Pre-treatment with tetrodotoxin had no effect on the EFS-induced contractions of either corpora cavernosa or aortic rings."( Electrical field stimulation-induced contractions on Pantherophis guttatus corpora cavernosa and aortae.
Antunes, E; Campos, R; Cogo, JC; De Nucci, G; Justo, AFO; Mónica, FZ; Moreno, RA; Oliveira, ET, 2018
)
0.8
"Pretreatment with tetrodotoxin, at a dose of 1μg/kg, s.c., slightly but significantly reduced the number of fenvalerate (3μg/ml)-induced coughs."( Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex.
Asato, M; Hayashi, SS; Ishikawa, Y; Kamei, J; Nakanishi, Y; Ohsawa, M, 2011
)
1
"Pretreatment with tetrodotoxin prevented the action of gabazine, but had no effect on the THIP-induced current."( Tonic GABAA receptor conductance in medial subnucleus of the tractus solitarius neurons is inhibited by activation of μ-opioid receptors.
Dretchen, KL; Gillis, RA; Herman, MA; Sahibzada, N; Vicini, S, 2012
)
0.7
"Pretreatment with tetrodotoxin prevented the alterations induced by veratrine."( Mouse extensor digitorum longus and soleus show distinctive ultrastructural changes induced by veratrine.
Da Cruz Höfling, MA; Dal Pai Silva, M; Silva Freitas, EM, 2002
)
0.64
"Pretreatment with tetrodotoxin (TTX) (10(-6) mol/L) or atropine (10(-5) mol/L) markedly reduced 5-HT-stimulated duodenal bicarbonate secretion (by 60% and 65%, respectively; P < 0.001) and Isc (by 45% and 27%, respectively; P < 0.001 and P < 0.05)."( Effect of 5-hydroxytryptamine on duodenal mucosal bicarbonate secretion in mice.
Isenberg, JI; Tuo, BG, 2003
)
0.64
"Pretreatment with tetrodotoxin (1 micrograms/ml for 15 min) substantially reduced the magnitude of the increase in the rate of release of SP but did not abolish it."( Release of substance P from the enteric nervous system: direct quantitation and characterization.
Baron, SA; Gintzler, AR; Jaffe, BM, 1983
)
0.59
"Pretreatment with tetrodotoxin completely antagonized the T17 depolarizing action."( Depolarizing action of a red-tide dinoflagellate brevetoxin on axonal membranes.
Baden, DG; Huang, JM; Wu, CH, 1984
)
0.59
"Pretreatment with tetrodotoxin completely abolished this reflex activity."( Neuroregulation of a chemosensitive afferent system in the canine distal esophagus.
DeSautel, MG; Maher, JW; Sandler, AD; Schlegel, JF, 1993
)
0.61
"Pretreatment with tetrodotoxin (0.3 microM; a Na+ channel blocker) or glycerol (a T tubule uncoupler) however, significantly reduced the triphenyltin-induced contracture."( Studies on the contracture inducing action of triphenyltin in the mouse diaphragm.
Liu, SH; Shiau, SY, 1994
)
0.61
"Pretreatment with tetrodotoxin (TTX, 5 microM), (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine hydrogen maleato (MK801, 1 microM) or muscimol (1 microM) inhibited SNP-induced increases in extracellular DA and decreases in DOPAC (TTX, complete block; MK801, 75% inhibition; muscimol, 80% inhibition)."( [Effect of nitric oxide on central dopaminergic neurons].
Nakahara, K; Shigemori, M; Tanaka, M; Yokoo, H; Yoshida, M, 1994
)
0.61
"Pretreatment with tetrodotoxin or omission of calcium in the incubation medium did not alter the responses of the D2 agonists, but it reversed the changes in PKC activity induced by the D1 agonists and converted the biphasic response of apomorphine to a monophasic inhibition."( Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
Giambalvo, CT; Wagner, RL, 1994
)
0.61
"Pretreatment with tetrodotoxin reduced the peak increase in SCC elicited by 5-MeOT and ICS 205-930 by 41 and 50%, respectively."( ICS 205-930 reduces 5-methoxytryptamine-induced short-circuit current in stripped pig jejunum.
Hansen, MB, 1994
)
0.61
"Pretreatment with tetrodotoxin had no effect on the initial ISC, max but prevented its maintenance."( Neurally maintained hypersecretion in undernourished rat intestine activated by E. coli STa enterotoxin and cyclic nucleotides in vitro.
Levin, RJ; Nzegwu, HC, 1994
)
0.61
"Treatment with tetrodotoxin, Mg2+, or kynurenate did not affect the increase in BFcrb elicited by systemic hypercapnia or by topical application of the nitric oxide donor 3-morpholino sydnonimine (P > 0.05 from Ringer solution)."( Neural mechanisms of blood flow regulation during synaptic activity in cerebellar cortex.
Iadecola, C; Li, J; Xu, S; Yang, G, 1996
)
0.63
"Treatment with tetrodotoxin did not reveal the presence of an inward sodium current."( Ionic signals in T47D human breast cancer cells.
Fay, MJ; Gallagher, JD; McCann, FV; North, WG, 1996
)
0.63
"Pretreatment with tetrodotoxin (TTX, 3.13 microM) diminished but did not prevent the guanidine-induced morphological abnormalities in the muscle cells."( Myonecrosis induced by guanidine in the mouse isolated phrenic nerve diaphragm preparation.
Corrado, AP; Cruz-Höfling, MA; Leite, GB; Rodrigues-Simioni, L; Silva-Carvalho, I, 1997
)
0.62
"Pretreatment with tetrodotoxin (TTX) caused a significant pressure increase by gastric distension, reaching 17.0 +/- 1.7 cmH2O, suggesting mediation by neural pathways."( Characterization of vagal pathways mediating gastric accommodation reflex in rats.
Owyang, C; Takahashi, T, 1997
)
0.62
"Pretreatment with tetrodotoxin (TTX) (3-10 microM) or N(G)-nitro-L-arginine (100 microM) had little effect on the spontaneous contractility of the UUT, motility indexes (MIs) (contraction amplitude x contraction frequency) calculated after 20 min exposure were little affected by TTX or N(G)-nitro-L-arginine (L-NOARG)."( Stretch-evoked inhibition of spontaneous migrating contractions in a whole mount preparation of the guinea-pig upper urinary tract.
Lang, RJ; Teele, ME, 1998
)
0.62
"Pretreatment with tetrodotoxin (TTX, 60 min, 1 microM), which abolished the basal release of DA and 5-HT into striatal dialysates, diminished the increase in DA concentrations induced by phentermine, but did not completely block it."( Effects of phentermine on striatal dopamine and serotonin release in conscious rats: in vivo microdialysis study.
Balcioglu, A; Wurtman, RJ, 1998
)
0.62
"Pretreatment with tetrodotoxin (1 microM) markedly reduced the relaxation and desensitization with capsaicin (10 microM) significantly inhibited the relaxation."( Endothelium-dependent sensory non-adrenergic non-cholinergic vasodilatation in rat thoracic aorta: involvement of ATP and a role for NO.
Huh, IH; Lee, YW; Park, JI; Shin, CY; Sohn, UD, 2000
)
0.63
"Treatment with tetrodotoxin or dimethylamirolide (DMA) dose-dependently attenuated the ischemia- and reperfusion-induced increase in myocardial sodium and enhanced the post-ischemic recovery of the LVDP."( Contribution of sodium channel and sodium/hydrogen exchanger to sodium accumulation in the ischemic myocardium.
Kajiwara, H; Takasaki, A; Takeo, S; Tanonaka, K, 2000
)
0.65
"Pretreatment with tetrodotoxin (1 ng/ml) prevented the ultrastructural changes caused by veratrine."( Histoenzymological and ultrastructural changes in lateral muscle fibers of Oreochromis niloticus (Teleostei: Cichlidae) after local injection of veratrine.
da Cruz-Höfling, A; Dal Pai Silva, M; Silva Freitas, M, 2001
)
0.63
"Pretreatment with tetrodotoxin (TTX) 1.6 X 10(-7) M prevented or reversed the initial increases in Vmax, height and TD induced by guanethidine (4 X 10(-4) M)."( Action of guanethidine on rabbit atrial membranes.
Misu, Y; Nishio, H, 1978
)
0.58
"Pretreatment by tetrodotoxin suppressed both the muscle fasciculations and the appearance of myopathies."( Role of muscle fasciculations in the generation of myopathies in mammalian skeletal muscle.
Adler, M; Hinman, D; Hudson, CS, 1992
)
0.62
"Pretreatment with tetrodotoxin (780 nM) or atropine (500 nM) partially decreased the contractile response to substance P, while methysergide (3 microM) did not decrease the response."( Contractile response to substance P in isolated smooth muscle strips from the intestinal bulb of the carp (Cyprinus carpio).
Furuhashi, H; Kimura, A; Kitazawa, T; Kondo, H; Temma, K, 1988
)
0.6
"3. Treatment with tetrodotoxin (0.1 microM) or cold storage of individual preparations to prevent nerve-mediated responses abolished the effects of cysteamine."( Interactions of the ulcerogen cysteamine with enteric inhibitory nerves and putative transmitters in the rat small intestine.
Krantis, A; Krause, C, 1989
)
0.6
"Treatment with tetrodotoxin at concentrations of 0.1 to 1.0 micromolar protected some hearts from fibrillation, while at concentrations above 3 micromolar ventricular fibrillation was not inducible."( Tetrodotoxin: sodium channel specific anti-arrhythmic activity.
Cannon, NJ; Duff, HJ; Sheldon, RS, 1988
)
2.06

Toxicity

Tetrodotoxin (TTX) is an extremely toxic marine compound produced by different genera of bacteria. It can reach humans through ingestion mainly of pufferfish but also of other contaminated fish species, marine gastropods or bivalves.

ExcerptReferenceRelevance
" In order to elucidate the in vivo influence of TTX on the toxic effects of aconitine, a mixture of aconitine and TTX was administered to male ICR mice orally or intraperitoneally."( The influence of tetrodotoxin on the toxic effects of aconitine in vivo.
Chiba, S; Kimura, K; Mizugaki, M; Nagamori, H; Ohno, Y; Ohyama, Y; Suzuki, Y; Uchigasaki, S; Uchima, E, 1992
)
0.62
" The puffer were toxic throughout most of the year."( Toxicity of the freshwater puffer fish Tetraodon fangi and T. palembangensis from Thailand.
Anuchatvorakul, B; Laobhripatr, S; Leelasitorn, S; Limpakarnjanarat, K; Saitanu, K; Sangwanloy, O; Sudhasaneya, S, 1991
)
0.28
" Survival time was prolonged in rats treated with the toxic metals by pretreatment with NKK-105."( Effects of diiospropyl-1,3-dithiol-2-ylidene malonate (NKK-105) on acute toxicity of various drugs and heavy metals.
Hosokawa, T; Kitagawa, H; Saito, H; Sakamoto, K; Sugimoto, T; Yanaura, S, 1982
)
0.26
" In addition, Tat, at similar concentrations, was toxic to human fetal neurons in culture."( Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity.
Brownstone, RM; Geiger, JD; Knudsen, BE; Magnuson, DS; Nath, A, 1995
)
0.29
" The constant perfusion (1 h) of glutamate 50 microM was toxic to the neurons."( Glutamate effect on synaptic transmission mediates neurotoxicity in dissociated rat hippocampal neurons.
Yoon, KW, 1995
)
0.29
" The pathogenesis of this syndrome implicates immunopathological and toxic events such as the production of cytokines."( Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures.
Couratier, P; Diop, AG; Esclaire, F; Hugon, J; Lesort, M; Sindou, P, 1994
)
1.73
" From these observations, it is proposed that intrinsic functional inhibition in hippocampal circuits can reduce adverse effects of Abeta on the excitatory component."( Inhibitory neuronal activity can compensate for adverse effects of beta-amyloid in hippocampal neurons.
Graf, RA; Kater, SB, 1998
)
0.3
" Use of NONOate donors differing in half-life indicated that nitric oxide delivered in an enduring manner at relatively low concentration was more toxic than the same amount supplied rapidly at high concentration."( Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve.
Batchelor, AM; Garthwaite, G; Garthwaite, J; Goodwin, DA; Leeming, K, 2002
)
0.31
" It was also found that depolarizing conditions with a high potassium concentration (30 mm) were toxic to motoneurons."( Survival-promoting activity of nimodipine and nifedipine in rat motoneurons: implications of an intrinsic calcium toxicity in motoneurons.
Arakawa, Y; Nishijima, C; Shimizu, N; Urushidani, T, 2002
)
0.31
" The main toxic component of this himomushi toxin (HMT) was isolated from a pooled specimen (390 g; total toxicity 2,897,000MU) by a method that consisted of treatment with activated charcoal, chromatography on Bio-Gel P-2 and Bio-Rex 70 (H+ form), and finally crystallization from an acidified methanolic solution."( Paralytic toxicity in the ribbon worm Cephalothrix species (Nemertea) in Hiroshima Bay, Hiroshima Prefecture, Japan and the isolation of tetrodotoxin as a main component of its toxins.
Asakawa, M; Bessho, K; Ito, K; Kajihara, H; Mawatari, SF; Miyazawa, K; Noguchi, T; Shida, Y; Toyoshima, T; Tsunetsugu, S; Yamaguchi, C, 2003
)
0.52
"In order to utilize the puffer fish resources furthest and to develop traditional diet culture, a project on the safe eating of puffer fish resources was conducted."( [Study on the safe edible of puffer fish resources].
Bao, D; Cui, J; Gong, Q; Huang, H; Wang, M; Zhang, L, 2003
)
0.32
" TTX toxic doses for both intramuscular (i."( [Toxicity of tetrodotoxin towards mice and rabbits].
Gao, L; Huang, K; Rong, K; Xu, Q; Zhang, H, 2003
)
0.69
" Veratridine (100 microM) or ouabain alone (500 microM) were not toxic to the cells."( A novel toxicity-based assay for the identification of modulators of voltage-gated Na+ channels.
Weiser, T, 2004
)
0.32
" asellus extracts, indicating that TTX and its analogs are not the main toxic components of the extracts."( Toxicity and toxin identification in Colomesus asellus, an Amazonian (Brazil) freshwater puffer fish.
Bloch, C; de Freitas, JC; Fernandes, SC; Melo, JA; Oliveira, JS; Rodrigues Pires, O; Schwartz, CA, 2006
)
0.33
" Nausea and other toxicities were generally mild, but two patients experienced a serious adverse event, truncal and gait ataxia, that resolved over days."( An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain.
Chary, S; du Souich, P; Fisher, KM; Hagen, NA; Lapointe, B; Moulin, D; Ngoc, AH; Sellers, E, 2007
)
0.57
" However, the results obtained by mouse bioassay showed that the analogue is much less toxic than TTX."( First toxicity report of tetrodotoxin and 5,6,11-trideoxyTTX in the trumpet shell Charonia lampas lampas in Europe.
Alfonso, A; Alfonso, C; Botana, LM; Rodriguez, P; Tellez, A; Vale, C; Vale, P, 2008
)
0.65
" We studied bacteria isolated from toxic snails as well as their habitat to probe into the relationship between bacteria and toxicity of nassariid gastropod."( [Toxicity screening and identification of bacteria isolated from snails Nassarius semiplicatus and their habitat].
Gu, Z; Luo, X; Shen, J; Wang, X; Yu, R; Zhou, M, 2008
)
0.35
" TTX content in the toxic strains was very low, which ranged from 15 ng/g to 96 ng/g."( [Toxicity screening and identification of bacteria isolated from snails Nassarius semiplicatus and their habitat].
Gu, Z; Luo, X; Shen, J; Wang, X; Yu, R; Zhou, M, 2008
)
0.35
" Toxic components were extracted and analyzed by LC/MS."( [The toxicity of starfishes, Astropecten genus, inhabiting the coast of Toyama Bay].
Kadota, N; Murakami, R; Narita, H; Noguchi, T, 2008
)
0.35
"In addition to inhibiting the excitation conduction process in peripheral nerves, local anesthetics (LAs) cause toxic effects on the central nervous system, cardiovascular system, neuromuscular junction, and cell metabolism."( Cytotoxicity of local anesthetics in human neuronal cells.
Blanck, TJ; Garavito-Aguilar, ZV; Patel, S; Perez-Castro, R; Recio-Pinto, E; Rosenberg, A; Xu, F; Zhang, J, 2009
)
0.35
" Lidocaine, linked to the highest incidence of transient neurological symptoms, was not the most toxic LA, whereas bupivacaine, a drug causing a very low incidence of transient neurological symptoms, was the most toxic LA in our cell model."( Cytotoxicity of local anesthetics in human neuronal cells.
Blanck, TJ; Garavito-Aguilar, ZV; Patel, S; Perez-Castro, R; Recio-Pinto, E; Rosenberg, A; Xu, F; Zhang, J, 2009
)
0.35
" In HPLC-FLD analyses, no paralytic shellfish poison component was detected in either of the two toxic species."( [Toxicity and toxin profiles of xanthid crabs collected around Nakanoshima in the Tokara Islands, Japan].
Arakawa, O; Nishibori, N; Nishio, S; Noguchi, T; Sagara, T; Takatani, T; Taniyama, S, 2009
)
0.35
" These results indicate that people should avoid eating unknown fish species from fish markets where harvested fish may include toxic species."( Liquid chromatography-tandem mass spectrometry determination of the toxicity and identification of fish species in a suspected tetrodotoxin fish poisoning.
Cheng, YJ; Hwang, DF; Jen, HC; Lin, SJ; Lin, TC; Pan, CH; Wu, YJ, 2011
)
0.58
" Our findings show that only the muscle of juveniles, the viscera of pre-adults, and muscle, liver, and gonad of adult specimens were slightly toxic (<1 mouse unit)."( Toxicity of cultured bullseye puffer fish Sphoeroides annulatus.
Campa-Cordova, AI; De la Parra, IA; Garcia-Ortega, A; Heredia-Tapia, A; Ibarra-Martinez, L; Nuñez-Vazquez, EJ; Ochoa, JL, 2012
)
0.38
" Liquid chromatography/mass spectrometry (LC-MS) revealed that the major toxic component was tetrodotoxin (TTX), which accounting for 13-82% of the total toxicity."( [Toxicity and toxin profile of scavenging and carnivorous gastropods from the coastal waters of Okinawa Prefecture, Japan].
Arakawa, O; Kubo, H; Ono, K; Oshiro, N; Sagara, T; Sorimachi, T; Tachibana, K; Takatani, T; Taniyama, S; Xiao, N, 2013
)
0.61
" In the livers of 4 individuals that were partially toxic, the lethal potency of the toxic parts was less than 4 mouse units (MU)/g, and no part showed especially high toxicity."( [Distribution of toxicity in liver of wild pufferfish Takifugu rubripes].
Arakawa, O; Nakajima, R; Niina, S; Noguchi, T; Okada, Y; Sakakura, Y; Takao, H; Takatani, T; Taniguchi, K; Tatsuno, R; Wang, J; Yamanaka, Y, 2013
)
0.39
" In September 2014, contamination of boiled and dried whitebait products with pufferfish juveniles became a serious food safety concern, as tiger pufferfish Takifugu rubripes juveniles are toxic and contain tetrodotoxin (TTX)."( [Molecular Identification and Toxicity of Pufferfish Juveniles Contaminating Whitebait Products].
Ishizaki, S; Kiriake, A; Matsuura, K; Nagashima, Y; Ohta, A; Okayama, S, 2016
)
0.62
" As a part of the risk assessment process leading to a safe seafood level for TTX, oral toxicity data are required."( Acute Oral Toxicity of Tetrodotoxin in Mice: Determination of Lethal Dose 50 (LD50) and No Observed Adverse Effect Level (NOAEL).
Abal, P; Alvarez, M; Antelo, A; Botana, LM; Cagide, E; Louzao, MC; Vieytes, MR; Vilariño, N, 2017
)
0.77
"Tetrodotoxin (TTX) is an extremely toxic marine compound produced by different genera of bacteria that can reach humans through ingestion mainly of pufferfish but also of other contaminated fish species, marine gastropods or bivalves."( Acute Toxicity Assessment: Macroscopic and Ultrastructural Effects in Mice Treated with Oral Tetrodotoxin.
Abal, P; Botana, LM; Louzao, MC; Vieytes, MR; Vilariño, N, 2019
)
2.18
" However, the European Food Safety Authority (EFSA) has established a safety level of 44 µg/kg TTX as the amount of toxin that did not cause adverse effects in humans."( Oral Chronic Toxicity of the Safe Tetrodotoxin Dose Proposed by the European Food Safety Authority and Its Additive Effect with Saxitoxin.
Boente-Juncal, A; Botana, LM; Camiña, M; Otero, P; Rodríguez, I; Rodriguez-Vieytes, M; Vale, C, 2020
)
0.84
" As a consequence, in 2017 the European Food Safety Authority (EFSA) released an opinion with reference to TTX present in marine gastropods and bivalves, proposing a safety limit of 44 µg/kg TTXs in shellfish meat, below which no adverse effects should be observed in humans."( Tetrodotoxin in live bivalve mollusks from Europe: Is it to be considered an emerging concern for food safety?
Antonelli, P; Arcangeli, G; Barco, L; Bordin, P; Losasso, C; Orsini, M; Peruzzo, A; Salerno, B, 2022
)
2.16
" Constantly increasing intoxications and the lack of specific antitoxic drugs in clinical applications highlight the need for further research into the toxic effects of TTX."( Acute Toxic Effects of Tetrodotoxin in Mice via Intramuscular Injection and Oral Gavage.
Huang, Y; Li, J; Song, J; Wang, F; Wang, Q; Zhang, F; Zhang, L; Zou, S, 2023
)
1.22
"Tetrodotoxin (TTX) is an exceedingly toxic non-protein biotoxin that demonstrates remarkable selectivity and affinity for sodium channels on the excitation membrane of nerves."( Transcriptomic Profiling of Tetrodotoxin-Induced Neurotoxicity in Human Cerebral Organoids.
Chen, X; Li, L; Liu, Z; Shi, J; Shi, T; Wang, Z; Wei, Y, 2023
)
2.65

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic studies (absorption, distribution and accumulation) reported on Takifugu rubripes, Takifugu pardalis, Takifugu niphobles, Takifugu vermicularis, Takifugu snyderi, etc."( Binding and Pharmacokinetics of the Sodium Channel Blocking Toxins (Saxitoxin and the Tetrodotoxins).
Pratheepa, V; Vasconcelos, V, 2017
)
0.68

Compound-Compound Interactions

ExcerptReferenceRelevance
"Tetrodotoxin (TTX), alone and in combination with various vasoconstrictors and local anesthetics, was evaluated for its ability to produce peripheral nerve blocks in the rat and central neural blocks in the cat and dog."( The local anesthetic activity of tetrodotoxin alone and in combination with vasoconstrictors and local anesthetics.
Adams, HJ; Blair, MR; Takman, BH,
)
1.86
" In some experiments hypoxia was combined with glucose withdrawal."( Effect of MK-801 on dopamine release evoked by hypoxia combined with hypoglycemia.
Milusheva, E, 1992
)
0.28
" With appropriate design of push-pull cannula and recording chamber, therefore, stable electrophysiological recordings can be combined with localized extracellular fluid sampling and rapid and localized application of test solutions in an interface slice chamber."( Push-pull cannula for localized application of drugs and sampling of medium, combined with electrophysiological recordings in an interface slice chamber.
Do, KQ; Thomson, AM; West, DC, 1992
)
0.28
" Present results raise the possibility that Na+ channel blockers may be useful in protecting gray matter from hypoxic-ischemic injury, especially when combined with antiexcitotoxic approaches."( Sodium channel blockers reduce oxygen-glucose deprivation-induced cortical neuronal injury when combined with glutamate receptor antagonists.
Canzoniero, LM; Choi, DW; Lynch, JJ; Sensi, SL; Yu, SP, 1995
)
0.29
" However, it is not known how oxidative stress affects NA release in the brain alone or in combination with energy deprivation."( Non-synaptic release of [3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices.
Adám-Vizi, V; Baranyi, M; Milusheva, E; Shikova, L; Sperlágh, B; Tretter, L; Vizi, ES, 2003
)
0.32
" A reliable technique is needed to catheterize young animals aimed for in vivo testing combined with spinal cord electrophysiology, often limited by animal age, to facilitate pain research."( Atlanto-occipital catheterization of young rats for long-term drug delivery into the lumbar subarachnoid space combined with in vivo testing and electrophysiology in situ.
Kopach, O; Krotov, V; Voitenko, N, 2017
)
0.46
" Here, we have developed a competitive, lateral-flow immunochromatographic strip combined with quantum dot nanobeads (QDNBs) and gold nanoflowers (AuNFs)."( A new lateral-flow immunochromatographic strip combined with quantum dot nanobeads and gold nanoflowers for rapid detection of tetrodotoxin.
Cheng, Z; Fu, Q; Huang, C; Shen, H; Tang, Y; Xiao, M; Xu, F; Zhang, S, 2017
)
0.66

Bioavailability

ExcerptReferenceRelevance
" N-Nitro-L-arginine (NOLA) (5 x 10(-5) to 10(-4) M), an inhibitor of NO synthase, and haemoglobin (10(-5) M), which reduces bioavailability of NO, both reduced the amplitude of nerve-mediated relaxations to less than 50%, without affecting the ability of the muscle to relax."( Evidence that nitric oxide participates in non-adrenergic inhibitory transmission to intestinal muscle in the guinea-pig.
Furness, JB; Murphy, R; Shuttleworth, CW, 1991
)
0.28
" The rate of absorption of L-[14C]glucose, a passively absorbed molecule, from the lumen was used as an index of the permeability of the mucosa of a perfused segment."( Nutrient-induced changes in the permeability of the rat jejunal mucosa.
Bass, P; See, NA, 1993
)
0.29
"25 mg TTX/kg body weight) elucidated the bioavailability of TTX to be 62%."( Pharmacokinetics of tetrodotoxin in puffer fish Takifugu rubripes by a single administration technique.
Ishizaki, S; Kusuhara, H; Matsumoto, T; Nagashima, Y; Shimakura, K; Shiomi, K, 2008
)
0.67
"8 channels by PF-01247324 was studied using in vitro patch-clamp electrophysiology and the oral bioavailability and antinociceptive effects demonstrated using in vivo rodent models of inflammatory and neuropathic pain."( A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.
Alexandrou, AJ; Anand, P; Anand, U; Antonio, BM; Bagal, S; Bannon, AW; Brown, AR; Bungay, PJ; Butt, RP; Chapman, ML; England, S; Fuller, MD; Gerlach, AC; Kemp, M; Kirkup, AJ; Loucif, AJ; Mahoney, JH; Payne, CE; Prime, RL; Printzenhoff, DM; Roeloffs, R; Stevens, EB; Stockbridge, G; Theile, JW, 2015
)
0.42

Dosage Studied

We studied the effects of atropine, tetrodotoxin (TTX) and neostigmine (10(-7) M) on the histamine dose-response curve of canine tracheal smooth muscle (TSM) in vitro. On isolated frog sartorius muscle fibers, chiriquitoxin is equipotent with tetrodtoxin in blocking the Na+ channel. In the presence of 22 mM K+, but not tetrodOToxin, the dose- response and temporal relationships between isoproterenol and elevations in cAMP were shifted to the right.

ExcerptRelevanceReference
" The dose-response curve to suxamethonium in tetrodotoxin 2 X 10(-7)M could be shifted to the right with tubocurarine 10(-6)M."( A mammalian muscle with the pharmacological characteristics of slow tonic muscle.
Dale, MM; Muid, R, 1978
)
0.52
"3 4-Aminopyridine causes a prallel shift to the right of the dose-response curve to Mg(2+) for blockade of nerve impulse-evoked transmitter release (in the absence of tetrodotoxin)."( 4-Aminopyridine and evoked transmitter release from motor nerve endings.
Illes, P; Thesleff, S, 1978
)
0.45
" Pretreatment with propranolol shifted the dose-response curves for the inotropic effect of both grayanotoxins slightly to the right."( The effects of grayanotoxin I and alpha-dihydrograyanotoxin II on guinea-pig myocardium.
Akera, T; Brody, TM; Frank, M; Iwasa, J; Ku, DD, 1977
)
0.26
" In vitro dose-response curves to gastrin I, CCK, and the octapeptide of CCK (OP) demonstrated that both CCK and OP were partial agonists on the LES muscle."( Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure.
Cohen, S; DiMarino, AJ; Fisher, RS, 1975
)
0.25
" Dose-response relationships for isoproterenol (IP) reveal a noncompetitive inhibition of the inotropic action of the catecholamine by ACh."( Catecholamine antagonism of acetylcholine and dibutyrl guanosine 3',-5'-monophosphate in the mammalian ventricular myocardium.
Jacob, R; Schwegler, M, 1975
)
0.25
" A submaximal gastrin dose added with OP-CCK, shifted the OP-CCK dose-response curve to the left and significantly reduced the D50, but the calculated maximal response (CMR) did not change."( Interaction between gastrin, CCK, and secretin on canine antral smooth muscle in vitro.
Berkowitz, JM; Fara, JW; Praissman, M, 1979
)
0.26
" The dose-response curve for the effect of carbachol gave a half-maximal value of 72 muM."( Sodium entry in rat diaphragm induced by depolarizing drugs.
Creese, R; Franklin, GI; Mitchell, LD, 1977
)
0.26
" Pretreatment of animals with reserpine or treatment of tissues with an alpha-adrenoceptor blocking agent failed to alter the dose-response relationship for ATP."( The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens.
Rowe, JN; Stitzel, RE; Westfall, DP, 1978
)
0.26
" The dose-response relationship was obtained by measuring a change in membrane resistance."( Effect of hemolysin produced by Vibrio parahaemolyticus on membrane conductance and mechanical tension of rabbit myocardium.
Honda, T; Irisawa, H; Miwatani, T; Seyama, I; Takeda, Y, 1977
)
0.26
" High frequency and long duration of block can be attained if sufficiently high concentrations of TTX are used, although latency is long and high dosage may produce systemic toxicity."( The local anesthetic activity of tetrodotoxin alone and in combination with vasoconstrictors and local anesthetics.
Adams, HJ; Blair, MR; Takman, BH,
)
0.41
" 4 In the frog spinal cord GABA depolarized the dorsal roots presumably by mimicking the activity of the transmitter depolarizing the primary afferents; sigmoidal log dose-response curves for GABA were obtained."( A comparative study of the action of gamma-aminobutyric acid and piperazine on the lobster muscle fibre and the frog spinal cord.
Constanti, A; Nistri, A, 1976
)
0.26
" From the log-log transformation of dose-response curves it was proposed that more than one glutamate molecule was necessary to activate both the lobster and the frog receptor sites."( A comparative study of the effects of glutamate and kainate on the lobster muscle fibre and the frog spinal cord.
Constanti, A; Nistri, A, 1976
)
0.26
" The tetrodotoxin dose-response curve was best fitted by an equation describing binding to high- and low-affinity sites."( Characterization of the sodium current in single human atrial myocytes.
Arentzen, CE; Furukawa, T; Hartz, RS; Jia, H; Sakakibara, Y; Singer, DH; Wasserstrom, JA, 1992
)
0.8
" Dose-response curves to acetylcholine (ACh) and nicotine were established for pairs of tissues with and without epithelium, each pair receiving only one dose of nicotine."( Nicotine-induced airway smooth muscle contraction: neural mechanisms involving the airway epithelium. Functional and histologic studies in vitro.
Bleicher, S; Hahn, HL; Lang, M; Rausch, C; Zwerenz, S,
)
0.13
"001) of the mean dose-response relationship."( Cholinergic mechanisms involved with histamine hyperreactivity in immune rabbit airways challenged with ragweed antigen.
Ando, RE; Irvin, CG; Larsen, GL; Tanaka, DT, 1991
)
0.28
" The dose-response curves for the PTX-induced increases in [3H]ACh release and in [Ca2+]i were depressed by removing extracellular Ca2+ or by decreasing extracellular Na+ concentrations."( Mode of action of palytoxin on the release of acetylcholine from rat cerebrocortical synaptosomes.
Nakazato, Y; Satoh, E, 1991
)
0.28
" The shapes of the dose-response functions differed considerably between the drugs."( In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
Damsma, G; Fibiger, HC; Nomikos, GG; Wenkstern, D, 1990
)
0.28
" Activity-dependent plasticity was also blocked if spontaneous activity was suppressed with dilute tetrodotoxin (TTX; 5-10 nM), a dosage that reduces excitability of neurons but is insufficient to block sodium-dependent action potentials."( Calcium, network activity, and the role of NMDA channels in synaptic plasticity in vitro.
Fields, RD; Nelson, PG; Yu, C, 1991
)
0.5
" On the other hand, the dose-response relationship to carbachol, a cholinergic agonist resistant to cholinesterase degradation, was unaffected by CTZ."( The effect of chlorothiazide on neurally mediated contraction of rabbit bronchial smooth muscle.
Brunner, SL; Scott, JY; Tanaka, DT, 1992
)
0.28
" Dose-response studies of intestinal muscle after 3 mo of untreated diabetes showed normal tension development to both bethanechol chloride and physostigmine."( Adaptation of cholinergic enteric neuromuscular transmission in diabetic rat small intestine.
Harrington, B; Kalbfleisch, J; Nowak, TV, 1990
)
0.28
" Dose-response curves to noradrenaline were unaffected by prazosin (1 microM)."( Alpha 2-adrenoceptor antisecretory responses in the rat jejunum.
Dettmar, PW; Downing, OA; Roach, AG; Urquhart, CJ; Williams, RJ; Wilson, KA, 1990
)
0.28
" Atropine or tetrodotoxin (TTX) caused a similar rightward shift of the CCK-8 dose-response curve for stimulation of SO contraction."( Characterization of cholecystokinin receptors on the sphincter of Oddi.
Cox, KL; Gardner, JD; Jensen, RT; Moran, TH; von Schrenck, T, 1990
)
0.65
"9 micrograms tetrodotoxin intracamerally had no clear effect on the dose-response relationship for CCK-8."( Cholecystokinin causes contraction of the pupillary sphincter in monkeys but not in cats, rabbits, rats and guinea-pigs: antagonism by lorglumide.
Almegård, B; Andersson, SE; Bill, A, 1990
)
0.65
" The dose-response curve of the steady state effect of tetrodotoxin on the fast current was sigmoid."( Cooperativity of tetrodotoxin action in the frog node of Ranvier.
Benoit, E; Dubois, JM, 1985
)
0.86
" At a concentration of (+)-nicardipine (10(-7) M) which inhibits most of the release stimulated by 50 mM potassium, the response to 3 X 10(-5) M nicotine remains; however, the dose-response curve to nicotine is shifted slightly to the left."( Stimulus secretion coupling in cultured chromaffin cells. Dependency on external sodium and on dihydropyridine-sensitive calcium channels.
Adams, M; Boarder, MR; Marriott, D, 1987
)
0.27
" Our observations thus support the conclusions of other workers who used mixtures of two local anesthetics to show that the dose-response behavior does not fit single-site behavior, but requires at least two distinct sites."( Isochannels and blocking modes of voltage-dependent sodium channels.
Guo, X; Heiny, J; Moczydlowski, E; Uehara, A, 1986
)
0.27
" Dose-response curves indicated a stoichiometry of 2, which suggested the aggregation of 2 molecules of PTX to form a channel."( Does palytoxin open a sodium-sensitive channel in cardiac muscle?
Berton, J; Pater, C; Sauviat, MP, 1987
)
0.27
" From dose-response curves the half-maximum effective dose (ED50) for glutamate and kainate was 3 X 10(-5) and 2 X 10(-4) M respectively."( The action of excitatory amino acids on chick spinal cord neurones in culture.
Vlachová, V; Vyklický, L; Vyskocil, F, 1987
)
0.27
"In examining the relation between the maximum upstroke velocity of the action potential (Vmax) and available Na conductance (agNa), the dose-response curve for tetrodotoxin (TTX) and the steady-state inactivation (h infinity)-membrane potential curve were obtained by measuring Na current (INa) as well as Vmax in single isolated frog ventricular cells."( Does the maximum upstroke velocity of the action potential (Vmax) represent available sodium conductance in frog ventricular cells?
Yamaoka, K, 1987
)
0.47
" Calcitonin gene-related peptide relaxed gastric smooth muscle, however, a dose-response relationship could not be established."( Effect of capsaicin on gastric corpus smooth muscle of the rat in vitro.
Holzer-Petsche, U; Lembeck, F; Seitz, H, 1989
)
0.28
" However, the effect of carbamazepine (100 microM) on the respective dose-response curves suggests that the mechanism of inhibition of the carbachol response differs from the inhibition of the histamine and veratrin responses."( Inhibition of agonist-stimulated inositol lipid metabolism by the anticonvulsant carbamazepine in rat hippocampus.
Logan, SD; McDermott, EE, 1989
)
0.28
" Atropine shifted the dose-response curve of CCK-OP in pylorus, duodenum and antrum to the right suggesting a neural action of CCK-OP."( Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
Allescher, HD; Daniel, EE; Fox, JE; Kostolanska, F; Rovati, LA, 1989
)
0.28
"8 mM), the dose-response curve for ATP was shifted to the left in a parallel fashion at this concentration."( Low calcium and calcium antagonists potentiate the contraction of guinea-pig vas deferens induced by ATP: a permissive role for P2-purinoceptors.
Furukawa, T; Morishita, H, 1989
)
0.28
" Neither GE 410 nor dbcGMP affected the ACH and histamine (His) response of the muscle strips but both antagonists shifted the dose-response curve of CCK 7 to the right, GE 410 (cholecystokinin antagonist) being a much more potent antagonist of CCK 7 as compared to dbcGMP."( Responses of guinea-pig gastric, ileal and gall bladder smooth muscle to desamino-cholecystokinin-octapeptide (CCK 7).
Henklein, P; Milenov, K; Nieber, K; Oehme, P; Rakovska, A, 1988
)
0.27
" In this preparation, all these antagonists shifted the NMDA dose-response curve to the right in a parallel manner."( Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex.
Harrison, NL; Simmonds, MA, 1985
)
0.27
" Analysis of iontophoretic dose-response curves indicated that DL-APV was a competitive antagonist."( Action of excitatory amino acids and their antagonists on hippocampal neurons.
Hablitz, JJ, 1985
)
0.27
" Dose-response curves for the relatively specific ligands for the mu-, kappa-, and sigma-receptors were determined using morphine (mu-receptors), dynorphin-(1-13) (kappa-receptors), and N-allylnormetazocine (sigma-receptors)."( Sites of action of mu-, kappa- and sigma-opiate receptor agonists at the feline ileocecal sphincter.
Cohen, S; Ouyang, A; Vos, P, 1988
)
0.27
" We found that excitatory amino acid agonists evoked somatostatin release in the following order of potency: quisqualate greater than glutamate = N-methyl-D-aspartate (NMDA) greater than kainate, as calculated from the dose-response curves."( Glutamate stimulates somatostatin release from diencephalic neurons in primary culture.
Astier, H; Tapia-Arancibia, L, 1988
)
0.27
" Tityustoxin caused a slight leftward shift of the dose-response curves to adrenaline and norepinephrine and a large potentiation of the frequency-response curves to electrical stimulation."( Effects of tityustoxin on the rat isolated tail artery.
Catanzaro, OL; Savino, EA, 1985
)
0.27
" In an apparently all-or-none manner, both caused a sinistral shift in dose-response curves for the phasic component of the contractile response to histamine at H1 receptors on the ileum."( Metronidazole and 5-aminosalicylic acid enhance the contractile activity of histaminergic agonists on the guinea-pig isolated ileum.
Barker, LA; Winbery, SL, 1986
)
0.27
" Dose-response relationships showed a close association between seizure activity (measured by EEG) and extracellular Ca2+ changes in the injected area."( Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis.
Angelico, P; Samanin, R; Stasi, MA; Vezzani, A; Wu, HQ, 1988
)
0.27
" Proglumide shifted the dose-response curves of the inhibitory as well as excitatory effects of CCK analogues to the right."( Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter.
Goyal, RK; Rattan, S, 1986
)
0.27
" When the concentration was raised to between 100 and 300 microM, however, the convulsants all reduced the monosynaptic reflex, thus producing a biphasic dose-response relationship."( Differing actions of convulsant and nonconvulsant barbiturates: an electrophysiological study in the isolated spinal cord of the rat.
Johnston, GA; Nicholson, GM; Spence, I, 1988
)
0.27
" The dose-response relation of the coronary diameter to histamine was not influenced by pretreatment with the nerve transmitter blockers guanethidine (3 X 10(-6) M), atropine (10(-6) M), and tetrodotoxin (3 X 10(-7) M)."( Pathogenesis of coronary artery spasm in miniature swine with regional intimal thickening after balloon denudation.
Egashira, K; Kawasaki, T; Kobayashi, T; Nakamura, M; Tomoike, H; Yamamoto, Y, 1987
)
0.46
" ICS 205-930 caused a parallel shift to the right of the dose-response curve for 5-HT."( Activation of 5-HT3 receptor subtypes causes rapid excitation of rabbit parasympathetic neurones.
Akasu, T; Hasuo, H; Tokimasa, T, 1987
)
0.27
" The dose-response curves for synaptosomal 22Na uptake and for the inotropic effect on guinea pig left atria are parallel for sulmazole and the quinazolone drug, with first an increase and then a decrease in activity."( Effect of some new cardiotonic agents on synaptosomal sodium uptake.
Decker, N; Grima, M; Schwartz, J, 1986
)
0.27
" Propranolol also shifted the dose-response curves to the right, but was apparently more potent in preparations with basal tone than in tissues where high tone was induced by carbachol or K+."( Noradrenergic and non-noradrenergic relaxation at basal and high tone levels in the guinea-pig tracheal smooth muscle.
Abe, M; Furukawa, T, 1986
)
0.27
" Both in vivo and in vitro methods demonstrated a leftward shift of the dose-response curve for nicotine in denervated hearts, indicative of denervation hypersensitivity."( Comparison of in vivo and in vitro cholinergic responses of normal and denervated canine hearts.
Anagnostelis, C; Priola, DV; Smith, DC, 1985
)
0.27
" Histamine-content, anaphylactic histamine-release and the anaphylactic dose-response curve of the full-thickness ileum and of the longitudinal muscle strip have been measured and compared."( The Schultz-Dale response of the longitudinal muscle strip preparation of guinea-pig ileum.
Dale, MM; Zilletti, L, 1970
)
0.25
" Hexamethonium and hyoscine did not affect the dose-response relationship for NA."( Studies of the interaction of 5-hydroxytryptamine and the perivascular innervation of the guinea-pig caecum.
Drakontide, AB; Gershon, MD, 1972
)
0.25
" The data obtained fit a dose-response curve modified to incorporate the correction for partial irreversibility when calculated for a one-to-one stoichiometry."( Equilibrium and kinetic properties of the interaction between tetrodotoxin and the excitable membrane of the squid giant axon.
Adelman, WJ; Cuervo, LA, 1970
)
0.49
" Log dose-response curves to oxotremorine and acetylcholine were similar and both drugs were competitively antagonized by atropine."( Investigation of the mechanism of action of oxotremorine on the guinea-pig isolated ileum preparation.
Cox, B; Hecker, SE, 1971
)
0.25
" Also the data on dosage-response to TTX of real axons fit the dose-response relationship of a hypothetical system in which one TTX ion binds reversibly to its receptor to produce a fraction of the inhibitory effect, the curve being identical to a simple adsorption isotherm."( Effect of low sodium, tetrodotoxin, and temperature variation upon excitation.
Barnhill, R; Guttman, R, 1968
)
0.56
" Atropine caused a dose-dependent rightward shift in the dose-response curves of inhibitory and excitatory effects of the two muscarinic agonists."( Pharmacologic identification, activation and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter.
Gilbert, R; Goyal, RK; Rattan, S, 1984
)
0.27
" On isolated frog sartorius muscle fibers, chiriquitoxin is equipotent with tetrodotoxin in blocking the Na+ channel, as shown by their identical dose-response relations on the maximum rate of rise of the action potential."( Tetrodotoxin, saxitoxin, chiriquitoxin: new perspectives on ionic channels.
Kao, CY, 1981
)
1.93
" accommodation was enhanced) at the anesthetic dosage level."( A comparison of the effects of pentobarbital and diphenylhydantoin on the GABA sensitivity and excitability of adult sensory ganglion cells.
Connors, BW, 1981
)
0.26
" The dose-response curve was shifted to the right in the presence of these blocking agents."( Further evidence for the involvement of Na+ channels in the release of adrenal catecholamine: the effect of scorpion venom and grayanotoxin I.
Ito, S; Nakazato, Y; Ohga, A, 1981
)
0.26
" However, in the presence of 22 mM K+, but not tetrodotoxin, the dose-response and temporal relationships between isoproterenol and elevations in cAMP concentration were shifted to the right, whereas those for phosphorylase activation were shifted to the left."( Isoproterenol-induced restoration of contraction in K+-depolarized hearts: relationship to cAMP.
Friedman, WF; Ingebretsen, WR; Mayer, SE, 1981
)
0.52
" Supramaximal concentrations of PGI2-Na evoked a maximal response, in contrast to primary prostaglandins, the dose-response curves of which decline at supramaximal values."( Effect of prostacyclin on cardiac transmembrane currents.
Kecskeméti, V; Kelemen, K; Knoll, J; Markó, R, 1982
)
0.26
" A sigmoid dose-response curve was obtained for the phasic contraction."( Effect of sodium propionate on the contractile response of the rat ileum in situ.
Yajima, T, 1984
)
0.27
" TM-906 noncompetitively antagonized the contractile response to methacholine, and it caused a parallel shift of dose-response curves for the contractile response to CaCl2 to higher concentrations."( Effects of trimebutine maleate (TM-906) on the smooth muscles of isolated guinea pig gallbladder.
Magaribuchi, T; Takenaga, H; Tamaki, H, 1984
)
0.27
" In normal Tyrode's solution, flurazepam (1 X 10(-6), 1 X 10(-5) and 1 X 10(-4) M) noncompetitively shifted the dose-response curves for CaCl2 downwards."( Ca2+-antagonistic effects of flurazepam, a benzodiazepine derivative, on isolated guinea-pig left atria.
Akutagawa, K; Ishii, K; Makino, M, 1983
)
0.27
"5 G-I (3 x 10(-5) M) shifted the dose-response curves for noradrenaline (NA), acetylcholine and high-K contractions to the left in a parallel manner and slightly increased the maximal response to these agonists."( Contractions induced by grayanotoxin I in the guinea-pig vas deferens.
Ohizumi, Y, 1983
)
0.27
"We studied the effects of atropine (10(-10) to 10(-6) M), tetrodotoxin (TTX) (10(-6) g/ml), and neostigmine (10(-7) M) on the histamine dose-response curve of canine tracheal smooth muscle (TSM) in vitro."( Mechanisms of histamine-induced contraction of canine airway smooth muscle.
Irvin, CG; Martin, JG; Shenkier, T; Shore, S, 1983
)
0.51
" However, after addition of 1 micrograms/ml TTX to the PSS, the in situ Em in SHR followed a depolarizing NE dose-response curve similar to that observed in WKY (with or without TTX)."( Norepinephrine effect on in situ venous membrane potential in spontaneously hypertensive rats.
Contney, SJ; Harder, DR; Stekiel, WJ; Willems, WJ, 1981
)
0.26
" In Ca2+ -free buffer the BaCl2 dose-response curve was shifted to the right."( BaCl2-induced contractions in the guinea pig ileum longitudinal muscle: role of presynaptic release of neurotransmitters and Ca2+ translocation in the postsynaptic membrane.
Clement, JG, 1981
)
0.26
" When expressed as % of control, the dose-response to TTX was similar throughout denervation."( Alterations in membrane electrical properties during long-term denervation of rat skeletal muscles.
Sellin, LC; Thesleff, S, 1980
)
0.26
" The whole-cell dose-response curve suggests that activation of current by ACh increases up to at least 100 microM and that multiple ligand binding steps are involved."( Activation of nicotinic acetylcholine receptors on cultured Drosophila and other insect neurones.
Albert, JL; Lingle, CJ, 1993
)
0.29
" Pre-treatment with the unselective tachykinin receptor antagonist spantide or the NK1 receptor selective antagonist GR82334 caused a rightward shift of the dose-response curves for both fragments, while the CCK receptor antagonist loxiglumide had no inhibitory effect."( CGRP(8-37) and CGRP(32-37) contract the iris sphincter in the rabbit eye: antagonism by spantide and GR82334.
Almegård, B; Andersson, SE, 1993
)
0.29
" Atropine (10(-6) M) and tetrodotoxin (3 x 10(-7) M) did not affect NKA-induced contractions, but inhibited SP- and NKB-induced contractions; the dose-response curves for SP and NKB were rightwardly shifted by atropine."( Tachykinin-induced contractions in the circular muscle of guinea pig ileum.
Gomi, Y; Mizuno, K; Suzuki, N, 1994
)
0.59
" The dose-response curve to ATP appeared not to be monophasic: at the lower concentrations (10-300 microM) the curve was shallow, whilst at high concentrations (1-10 mM) the curve was steeper."( Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder.
Artibani, W; Calpista, A; Corsi, M; Palea, S; Pietra, C; Trist, DG, 1995
)
0.29
" NMDA increased [Ca2+]i transients and MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d')cyclohepten-5,10-imine hydrogen] reduced them, in a dose-response manner."( Characterization of spontaneous and N-methyl-D-aspartate-induced calcium rise in rat cultured hypothalamic neurons.
Dayanithi, G; Rage, F; Richard, P; Tapia-Arancibia, L, 1995
)
0.29
"The horseshoe crab, Carcinoscorpius rotundicauda, when injected intracardially with tetrodotoxin (TTX) at a dosage of 10 x LD50 of mice showed no mortality."( A tetrodotoxin neutralizing system in the haemolymph of the horseshoe crab, Carcinoscorpius rotundicauda.
Ding, JL; Ho, B; Yeo, DS, 1994
)
1.23
" Naloxone shifted to the right the dose-response curves for each opioid peptide significantly enhancing the ED50 values."( Modulation of non-adrenergic non-cholinergic inhibitory transmission in rat duodenum: role of opiates and 5-hydroxytryptamine.
Adamo, EB; Di Giovanni, G; Marini, R; Mulè, F; Postorino, A; Serio, R, 1993
)
0.29
" Tetrodotoxin (1 mumol/L) and atropine (1 mumol/L) caused a rightward shift of the dose-response curve for CCK-8-stimulated sphincter relaxation."( Characterization of cholecystokinin receptors on the human sphincter of Oddi.
Concepcion, W; Cox, KL; Esquivel, CO; Itasaka, H; Nakazato, P; Tokunaga, Y, 1993
)
1.2
" The dose-response curve and ED50 value for KCl were not different between neurogenic and control bladders."( [Response of the human neurogenic bladder induced by intramural nerve stimulation].
Kato, T; Kondo, A; Miyake, K; Saito, M, 1993
)
0.29
"The clinical symptoms and signs of TTX poisoning are similar to those of anticholinesterase poisons, and TTX dosing as described by this model may serve as a surrogate for organophosphorus poisoning."( Tetrodotoxin infusion: nonventilatory effects and role in toxicity models.
Barnas, GM; Mackenzie, CF; Park, SG; Smalley, AJ, 1996
)
1.74
" Block was well described by single-site dose-response relationships with no indication of a subpopulation with "neuronal" affinity."( Cardiac sodium channels expressed in a peripheral neurotumor-derived cell line, RT4-B8.
Ambler, KS; Hanck, DA; Kyle, JW; Martin, RL; Zeng, D, 1996
)
0.29
" When eNPY and adrenaline (AD) were applied simultaneously, the effects were additive only at lower dosage (3 x 10(-8) M for eNPY, 3 x 10(-8) M for AD), but not at high dosage (10(-6) M eNPY, 10(-7) M AD)."( Effects of eel neuropeptide Y on ion transport across the seawater eel intestine.
Ando, M; Sugimoto, S; Uesaka, T; Yano, K, 1996
)
0.29
" Inflammation induced a significant leftward shift in the inhibitory dose-response curve to methoctramine but not to 4-DAMP, pirenzepine, or tropicamide."( Inflammatory modulation of muscarinic receptor activation in canine ileal circular muscle cells.
Sarna, SK; Shi, XZ, 1997
)
0.3
" The dose-response curves to nicotinic agonists were bell shaped, and indicated that their functional efficacies and potency vary across agonists."( Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.
Balla, A; Lajtha, A; Sershen, H; Vizi, ES, 1997
)
0.3
" We now report that the dose-response relation indicates that this SAN Na+ channel has unusually high TTX sensitivity, with half-maximal inhibition (26 +/- 5 nM) which is more typical of neuronal than cardiac tissue."( The newborn rabbit sino-atrial node expresses a neuronal type I-like Na+ channel.
Baruscotti, M; Catterall, WA; DiFrancesco, D; Robinson, RB; Westenbroek, R, 1997
)
0.3
"15 nmol) of the potent Na+ channel blocker tetrodotoxin (TTX) was determined through a dose-response study."( Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury.
Teng, YD; Wrathall, JR, 1997
)
0.83
" Dose-response analysis of this effect revealed an IC50 of 48."( Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells.
Avoli, M; Ciotti, MT; Zona, C, 1997
)
0.3
" Evoked inhibitory postsynaptic currents (IPSCs) were decreased by kainate by up to 90%, showing a bell-shaped dose-response curve similar to that of native kainate-selective receptors."( Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus.
Herreras, O; Lerma, J; Rodríguez-Moreno, A, 1997
)
0.3
" The dose-response relation for IACh versus ACh concentration was fitted by the Hill equation with EC50 = approx."( Nicotinic acetylcholine sensitivity of rat petrosal sensory neurons in dissociated cell culture.
Nurse, CA; Zhong, H, 1997
)
0.3
" L-NNA shifted the acetylcholine dose-response curve to the left and amplified the response to low-dose acetylcholine."( Sites of nitric oxide (NO) actions in control of circular muscle motility of the perfused isolated canine ileum.
Daniel, EE; Fox-Threlkeld, JE; Woskowska, Z, 1997
)
0.3
" Capsaicin (10(-6) M) caused relaxation and desensitization that was overcome by long recovery periods and substance P dosing (10(-8) M)."( Activation of non-adrenergic non-cholinergic inhibitory pathways by endogenous and exogenous tachykinins in the ferret lower oesophageal sphincter.
Blackshaw, LA; Lynn, PA; Smid, SD; Templeman, R, 1998
)
0.3
" However, the inhibition of the combined CPA and CCh response was reduced and the dose-response curve of SIN-1 shifted to the right."( Involvement of intracellular Ca2+ stores in inhibitory effects of NO donor SIN-1 and cGMP.
Allescher, HD; Franck, H; Puschmann, A; Schusdziarra, V; Storr, M, 1998
)
0.3
" Higher dosage of verapamil are needed to block Na+ channels in adult avian heart as reported for mammalian myocardium."( Verapamil and TTX inhibit +Vmax but differentially alter the duration of action potential of adult chicken ventricular myocardium.
Prakash, P; Tripathi, O, 1998
)
0.3
" Dose-response curves to cholecystokinin-octapeptide and carbachol were first established."( Effect of somatostatin on human gallbladder motility: an in vitro study.
Caruso, ML; Lorusso, D; Maselli, MA; Pezzolla, F; Piepoli, AL, 1999
)
0.3
" Vagal ligation but not perivagal capsaicin treatment reduced the inhibitory effect of secretin on bethanechol-stimulated contraction of isolated forestomach muscle strips, causing a right shift in the dose-response curve."( Vagus nerve modulates secretin binding sites in the rat forestomach.
Chang, TM; Chey, WY; Kwon, HY; Lee, KY, 1999
)
0.3
" The 2 d agonist exposure (1 microM) caused a shift in the U69,593 dose-response curve that was greater in the potassium-stimulated paradigm (140-fold) than in the spontaneous release assay (sixfold)."( kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons.
Dalman, FC; O'Malley, KL, 1999
)
0.3
" In fact it showed: (1) very sensitive dose-response not affected by TTX in the bath; (2) an equilibrium potential compatible with Cl-channel conductance; (3) a massive reduction with the competitive GABA(A) antagonist bicuculline; (4) a small reduction, if any, with the potent competitive GABA(B) antagonist CGP55845A; (5) persistence of the responses under 4-AP (4-aminopyridine), the potassium channel blocker, and inhibition of the 4-AP-induced calcium bursts of spikes."( Purkinje cell inhibitory responses to 3-APPA (3-aminopropylphosphinic acid) in RAT cerebellar slices.
Batini, C; Vigot, R, 1999
)
0.3
" We investigated the dose-response relationship for each alcohol and determined that the order of potency was methanol < EtOH << octanol, with EC(50) values of 291 mM, 39."( Effect of ethanol upon respiratory-related hypoglossal nerve output of neonatal rat brain stem slices.
Berger, AJ; Gibson, IC, 2000
)
0.31
" The dose-response relation for GTX-modified Na(+) channels was constructed by plotting the normalized slope conductance against GTX concentration."( An analysis of the variations in potency of grayanotoxin analogs in modifying frog sodium channels of differing subtypes.
Furue, T; Imoto, K; Mori, Y; Seyama, I; Yakehiro, M; Yamaoka, K; Yuki, T, 2000
)
0.31
" In fetal, but not adult, MCA, UK-14304 induced a significant decrease in pD(2) for the phenylephrine dose-response relation."( Pre- and postjunctional alpha(2)-adrenergic receptors in fetal and adult ovine cerebral arteries.
Bishai, JM; Buchholz, JN; Gheorghe, CP; Longo, LD; Meulenaar, R; Nijland, R; Penninga, L; Zhang, L; Zhao, Y, 2002
)
0.31
"We established reproducible assays for human colon muscle strips by the generation of two complete dose-response curves to long-train EFS, thus enabling a "within-preparations" study."( A robust method for evaluation of NANC transmission in human sigmoid colon muscle in vitro.
Rennie, JA; Tavares, IA,
)
0.13
" However, inflammation induced a significant leftward shift in the circular muscle inhibitory dose-response curve of M(2) inhibitor."( Inflammation inhibits muscarinic signaling in in vivo canine colonic circular smooth muscle cells.
Jadcherla, SR, 2002
)
0.31
" Blocking properties followed a dose-response curve with a maximum effect at 10 microm."( Modulation of neuronal activity by the endogenous pentapeptide QYNAD.
Brock, R; Broicher, T; Budde, T; Duyar, H; Elbs, M; Landgraf, P; Meuth, SG; Weissert, R; Weller, M; Wiendl, H, 2003
)
0.32
" Dose-response curves estimated for three field-caught populations closely matched the curves estimated from neonate data."( Resistance of neonates and field-collected garter snakes (Thamnophis spp.) to tetrodotoxin.
Brodie, ED; Ridenhour, BJ, 2004
)
0.55
" The dose-response curves were shifted to the right by muscarinic antagonists in the following order of affinity: darifenacin (M(3))>methocramine (M(2)) >pirenzepine (M(1))."( Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.
Ouyang, A; Tandon, T; Wrzos, HF, 2004
)
0.32
" The TTX dose-response curve, using the whole cell voltage-clamp technique, showed three populations of fibres in senescent mice, one similar to fibres from young mice (TTX sensitive), another one similar to fibres from experimentally denervated muscle (TTX resistant), and a third group intermediate between these two."( Extension and magnitude of denervation in skeletal muscle from ageing mice.
Delbono, O; Messi, ML; Wang, ZM; Zheng, Z, 2005
)
0.33
" Dose-response curve for a beta-adrenergic agonist isoproterenol was constructed in the presence and absence of a CB-1 antagonist AM251 (1 microM)."( Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Baik, SK; Gaskari, SA; Lee, SS; Li, Y; Liu, H; Moezi, L, 2005
)
0.33
" Dose-response curves for carbachol revealed a lower peak response in new-born bladders compared with adults."( Developmental regulation of nerve and receptor mediated contractions of mammalian urinary bladder smooth muscle.
Andersson, KE; Arner, A; Ekman, M, 2006
)
0.33
" Validation showed that carbachol produced a dose-response curve closely mirroring that observed in the isolated muscle strips and demonstrated the dual nature of electrically evoked neurotransmission, consisting of a cholinergic component largely mediated by M(3) receptors and a purinergic component mediated by P2X receptors."( The use of the isolated mouse whole bladder for investigating bladder overactivity.
Brading, AF; Fabiyi, AC, 2006
)
0.33
" There was no significant difference between the dose-response curve for orexin-A and that for orexin-B."( Cytosolic calcium elevation induced by orexin/hypocretin in granule cell domain cells of the rat cochlear nucleus in vitro.
Kim, J; Miura, S; Nakamura, Y; Sasaki, K; Yoshida, T, 2010
)
0.36
" The linear portion of the dose-response curve of TTX concentration was in range 5-500 ng ml(-1)."( Development of competitive indirect ELISA for the detection of tetrodotoxin and a survey of the distribution of tetrodotoxin in the tissues of wild puffer fish in the waters of south-east China.
Fen, GX; Hui, HC; Jing, Z; Jun, LY; Lei, LH; Nan, L; Rong, J; Tao, J; Wei, WJ, 2010
)
0.6
" Moreover, qualitative differences between heterozygous and homozygous neurons with respect to certain synaptic properties indicate that the abnormalities observed in homozygotes may reflect more than a simple gene dosage effect."( Miniature release events of glutamate from hippocampal neurons are influenced by the dystonia-associated protein torsinA.
Gonzalez-Alegre, P; Harata, NC; Iwabuchi, S; Kakazu, Y; Koh, JY, 2012
)
0.38
" Exogenous BDNF administration facilitated the acquisition of strategy shifting by minimizing response perseveration to the previously acquired strategy and this effect resemble an inverted-U shaped dose-response pattern."( Exogenous BDNF facilitates strategy set-shifting by modulating glutamate dynamics in the dorsal striatum.
D'Amore, DE; Parikh, V; Tracy, BA, 2013
)
0.39
" Starting from the first day of the experiment, the rats in the (PONT+LBP) group and the (LBP) group were dosed with LBP; rats in the (PONT+PBS (phosphate buffered saline)) group and the (PBS) group were dosed with PBS via nasogastric tube every day until euthanized."( Effect of lycium barbarum (wolfberry) polysaccharides on preserving retinal function after partial optic nerve transection.
Chan, HH; Chin, MP; Chu, PH; Li, HY; So, KF, 2013
)
0.39
" The size of PPCs, their frequency and their rate of propagation were not affected by intra-arterial dosage with tetrodotoxin or lidocaine."( Characterisation of the contractile dynamics of the resting ex vivo urinary bladder of the pig.
Chambers, JP; Hulls, CM; Janssen, PW; King, QM; Lentle, RG; Reynolds, GW, 2015
)
0.63
" Specifically, we used dose-response curves to test the sensitivity of trematode cercariae to progressively increasing concentrations of TTX (0."( Noxious newts and their natural enemies: Experimental effects of tetrodotoxin exposure on trematode parasites and aquatic macroinvertebrates.
Bucciarelli, GM; Calhoun, DM; Johnson, PTJ; Kats, LB; Zimmer, RK, 2017
)
0.69
" In vitro concentration-response data of TTX obtained in a multielectrode array assay with primary rat neonatal cortical cells and in an effect study with mouse neuro-2a cells were quantitatively extrapolated into in vivo dose-response data, using newly developed physiologically based kinetic (PBK) models for TTX in rats and mice."( Use of Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Acute Toxicity of Tetrodotoxin in Rodents.
Noorlander, A; Rietjens, IMCM; van Ravenzwaay, B; Zhang, M, 2022
)
0.93
" In a recent study, mice were dosed with saxitoxin and tetrodotoxin mixtures daily for 28 days showing toxicity at low concentrations, which appeared to be at odds with other work."( A Sub-Acute Dosing Study of Saxitoxin and Tetrodotoxin Mixtures in Mice Suggests That the Current Paralytic Shellfish Toxin Regulatory Limit Is Fit for Purpose.
Boundy, MJ; Broadhurst, RB; Finch, SC; Harwood, DT; Munday, JS; Somchit, C; Sprosen, JM; Webb, NG, 2023
)
1.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
voltage-gated sodium channel blockerAny sodium channel blocker that interferes with the activity of voltage-gated sodium channels.
neurotoxinA poison that interferes with the functions of the nervous system.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
quinazoline alkaloidAny alkaloid based on a quinazoline skeleton and its substituted derivatives.
azatetracycloalkaneAny organic heterotetracyclic compound where at least one of the specified hetero atoms is nitrogen.
oxatetracycloalkaneAny organic heterotetracyclic compound where at least one of the specified hetero atoms is oxygen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium channel protein type 11 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)1.00001.00001.00001.0000AID1339913
Sodium channel protein type 1 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)0.01000.01001.14052.9390AID1339905
Sodium channel protein type 2 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)0.00930.00401.14854.7300AID1339906; AID146836; AID205296
Sodium channel protein type 3 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)0.01500.00600.86052.9390AID1339907
Sodium channel protein type 5 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)2.00002.00002.00002.0000AID1339909
Sodium channel protein type 1 subunit alphaHomo sapiens (human)IC50 (µMol)0.01700.00232.82969.0000AID1525388; AID726292
Sodium channel protein type 4 subunit alphaHomo sapiens (human)IC50 (µMol)0.02090.00013.507510.0000AID1339908; AID1525391; AID726289
Sodium channel protein type 7 subunit alphaHomo sapiens (human)IC50 (µMol)0.03600.03603.73359.0000AID1525384
Sodium channel protein type 5 subunit alphaHomo sapiens (human)IC50 (µMol)0.51500.00033.64849.2000AID1525392; AID726287
Sodium channel protein type 9 subunit alphaHomo sapiens (human)IC50 (µMol)0.02030.00602.77499.0000AID1339911; AID599097; AID726285
Sodium channel protein type 10 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)50.00000.04500.08500.1250AID1339912
Sodium channel protein type 2 subunit alphaHomo sapiens (human)IC50 (µMol)0.02200.00003.740110.0000AID1525389; AID726290
Sodium channel protein type 3 subunit alphaHomo sapiens (human)IC50 (µMol)0.01760.00532.80859.0000AID1525390; AID726291
Sodium channel protein type 11 subunit alphaHomo sapiens (human)IC50 (µMol)15.01500.03004.36959.0000AID1525446; AID726284
Sodium channel protein type 8 subunit alphaHomo sapiens (human)IC50 (µMol)0.01610.00113.47059.0000AID1525393; AID726288
Sodium channel protein type 8 subunit alphaMus musculus (house mouse)IC50 (µMol)0.00600.00600.00600.0060AID1339910
Sodium channel protein type 10 subunit alphaHomo sapiens (human)IC50 (µMol)15.01500.00803.17529.0000AID1525394; AID726286
Sodium channel protein type 9 subunit alphaHomo sapiens (human)IC50 (µMol)0.01860.00602.77499.0000AID1420146
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (98)

Processvia Protein(s)Taxonomy
sodium ion transportSodium channel protein type 1 subunit alphaHomo sapiens (human)
adult walking behaviorSodium channel protein type 1 subunit alphaHomo sapiens (human)
determination of adult lifespanSodium channel protein type 1 subunit alphaHomo sapiens (human)
neuronal action potential propagationSodium channel protein type 1 subunit alphaHomo sapiens (human)
neuronal action potentialSodium channel protein type 1 subunit alphaHomo sapiens (human)
nerve developmentSodium channel protein type 1 subunit alphaHomo sapiens (human)
neuromuscular process controlling postureSodium channel protein type 1 subunit alphaHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painSodium channel protein type 1 subunit alphaHomo sapiens (human)
establishment of localization in cellSodium channel protein type 1 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 1 subunit alphaHomo sapiens (human)
membrane depolarization during action potentialSodium channel protein type 1 subunit alphaHomo sapiens (human)
regulation of presynaptic membrane potentialSodium channel protein type 1 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 1 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 4 subunit alphaHomo sapiens (human)
muscle contractionSodium channel protein type 4 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 4 subunit alphaHomo sapiens (human)
regulation of skeletal muscle contraction by action potentialSodium channel protein type 4 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 4 subunit alphaHomo sapiens (human)
osmosensory signaling pathwaySodium channel protein type 7 subunit alphaHomo sapiens (human)
response to bacteriumSodium channel protein type 7 subunit alphaHomo sapiens (human)
cellular homeostasisSodium channel protein type 7 subunit alphaHomo sapiens (human)
sodium ion homeostasisSodium channel protein type 7 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 7 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 7 subunit alphaHomo sapiens (human)
regulation of heart rateSodium channel protein type 5 subunit alphaHomo sapiens (human)
cardiac conduction system developmentSodium channel protein type 5 subunit alphaHomo sapiens (human)
cardiac ventricle developmentSodium channel protein type 5 subunit alphaHomo sapiens (human)
brainstem developmentSodium channel protein type 5 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 5 subunit alphaHomo sapiens (human)
positive regulation of sodium ion transportSodium channel protein type 5 subunit alphaHomo sapiens (human)
response to denervation involved in regulation of muscle adaptationSodium channel protein type 5 subunit alphaHomo sapiens (human)
telencephalon developmentSodium channel protein type 5 subunit alphaHomo sapiens (human)
cerebellum developmentSodium channel protein type 5 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 5 subunit alphaHomo sapiens (human)
odontogenesis of dentin-containing toothSodium channel protein type 5 subunit alphaHomo sapiens (human)
positive regulation of action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
positive regulation of epithelial cell proliferationSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarizationSodium channel protein type 5 subunit alphaHomo sapiens (human)
cardiac muscle contractionSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of ventricular cardiac muscle cell membrane repolarizationSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of atrial cardiac muscle cell membrane depolarizationSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of atrial cardiac muscle cell membrane repolarizationSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of ventricular cardiac muscle cell membrane depolarizationSodium channel protein type 5 subunit alphaHomo sapiens (human)
cellular response to calcium ionSodium channel protein type 5 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of cardiac muscle cell contractionSodium channel protein type 5 subunit alphaHomo sapiens (human)
ventricular cardiac muscle cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during cardiac muscle cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
atrial cardiac muscle cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
SA node cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
AV node cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
bundle of His cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during AV node cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during SA node cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during Purkinje myocyte cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during bundle of His cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
AV node cell to bundle of His cell communicationSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of heart rate by cardiac conductionSodium channel protein type 5 subunit alphaHomo sapiens (human)
membrane depolarization during atrial cardiac muscle cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
regulation of sodium ion transmembrane transportSodium channel protein type 5 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 9 subunit alphaHomo sapiens (human)
inflammatory responseSodium channel protein type 9 subunit alphaHomo sapiens (human)
circadian rhythmSodium channel protein type 9 subunit alphaHomo sapiens (human)
response to toxic substanceSodium channel protein type 9 subunit alphaHomo sapiens (human)
post-embryonic developmentSodium channel protein type 9 subunit alphaHomo sapiens (human)
sensory perception of painSodium channel protein type 9 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 9 subunit alphaHomo sapiens (human)
behavioral response to painSodium channel protein type 9 subunit alphaHomo sapiens (human)
detection of temperature stimulus involved in sensory perception of painSodium channel protein type 9 subunit alphaHomo sapiens (human)
detection of mechanical stimulus involved in sensory perceptionSodium channel protein type 9 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 9 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 2 subunit alphaHomo sapiens (human)
nervous system developmentSodium channel protein type 2 subunit alphaHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to osmotic stressSodium channel protein type 2 subunit alphaHomo sapiens (human)
neuron apoptotic processSodium channel protein type 2 subunit alphaHomo sapiens (human)
memorySodium channel protein type 2 subunit alphaHomo sapiens (human)
determination of adult lifespanSodium channel protein type 2 subunit alphaHomo sapiens (human)
neuronal action potentialSodium channel protein type 2 subunit alphaHomo sapiens (human)
dentate gyrus developmentSodium channel protein type 2 subunit alphaHomo sapiens (human)
nerve developmentSodium channel protein type 2 subunit alphaHomo sapiens (human)
myelinationSodium channel protein type 2 subunit alphaHomo sapiens (human)
cellular response to hypoxiaSodium channel protein type 2 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 2 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 2 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 3 subunit alphaHomo sapiens (human)
behavioral response to painSodium channel protein type 3 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 3 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 3 subunit alphaHomo sapiens (human)
thigmotaxisSodium channel protein type 11 subunit alphaHomo sapiens (human)
acute inflammatory responseSodium channel protein type 11 subunit alphaHomo sapiens (human)
chronic inflammatory responseSodium channel protein type 11 subunit alphaHomo sapiens (human)
axonogenesisSodium channel protein type 11 subunit alphaHomo sapiens (human)
circadian rhythmSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to heatSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to xenobiotic stimulusSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to toxic substanceSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to high light intensitySodium channel protein type 11 subunit alphaHomo sapiens (human)
protein kinase A signalingSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to auditory stimulusSodium channel protein type 11 subunit alphaHomo sapiens (human)
neuronal action potentialSodium channel protein type 11 subunit alphaHomo sapiens (human)
sensory perception of painSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to prostaglandin ESodium channel protein type 11 subunit alphaHomo sapiens (human)
thermosensory behaviorSodium channel protein type 11 subunit alphaHomo sapiens (human)
mast cell degranulationSodium channel protein type 11 subunit alphaHomo sapiens (human)
cell motilitySodium channel protein type 11 subunit alphaHomo sapiens (human)
detection of temperature stimulus involved in sensory perception of painSodium channel protein type 11 subunit alphaHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painSodium channel protein type 11 subunit alphaHomo sapiens (human)
reflexSodium channel protein type 11 subunit alphaHomo sapiens (human)
micturitionSodium channel protein type 11 subunit alphaHomo sapiens (human)
skeletal muscle organ developmentSodium channel protein type 11 subunit alphaHomo sapiens (human)
artery developmentSodium channel protein type 11 subunit alphaHomo sapiens (human)
behavioral response to acetic acid induced painSodium channel protein type 11 subunit alphaHomo sapiens (human)
behavioral response to formalin induced painSodium channel protein type 11 subunit alphaHomo sapiens (human)
cellular response to coldSodium channel protein type 11 subunit alphaHomo sapiens (human)
calcium ion transmembrane transportSodium channel protein type 11 subunit alphaHomo sapiens (human)
response to nitric oxideSodium channel protein type 11 subunit alphaHomo sapiens (human)
membrane depolarization during action potentialSodium channel protein type 11 subunit alphaHomo sapiens (human)
action potential initiationSodium channel protein type 11 subunit alphaHomo sapiens (human)
sensory perception of itchSodium channel protein type 11 subunit alphaHomo sapiens (human)
calcitonin gene-related peptide receptor signaling pathwaySodium channel protein type 11 subunit alphaHomo sapiens (human)
small intestine smooth muscle contractionSodium channel protein type 11 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 11 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 11 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 8 subunit alphaHomo sapiens (human)
nervous system developmentSodium channel protein type 8 subunit alphaHomo sapiens (human)
peripheral nervous system developmentSodium channel protein type 8 subunit alphaHomo sapiens (human)
neuronal action potentialSodium channel protein type 8 subunit alphaHomo sapiens (human)
optic nerve developmentSodium channel protein type 8 subunit alphaHomo sapiens (human)
myelinationSodium channel protein type 8 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 8 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 8 subunit alphaHomo sapiens (human)
regulation of heart rateSodium channel protein type 10 subunit alphaHomo sapiens (human)
sensory perceptionSodium channel protein type 10 subunit alphaHomo sapiens (human)
regulation of monoatomic ion transmembrane transportSodium channel protein type 10 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 10 subunit alphaHomo sapiens (human)
odontogenesis of dentin-containing toothSodium channel protein type 10 subunit alphaHomo sapiens (human)
regulation of cardiac muscle contractionSodium channel protein type 10 subunit alphaHomo sapiens (human)
regulation of atrial cardiac muscle cell membrane depolarizationSodium channel protein type 10 subunit alphaHomo sapiens (human)
membrane depolarization during action potentialSodium channel protein type 10 subunit alphaHomo sapiens (human)
AV node cell action potentialSodium channel protein type 10 subunit alphaHomo sapiens (human)
bundle of His cell action potentialSodium channel protein type 10 subunit alphaHomo sapiens (human)
regulation of presynaptic membrane potentialSodium channel protein type 10 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 10 subunit alphaHomo sapiens (human)
sodium ion transportSodium channel protein type 9 subunit alphaHomo sapiens (human)
inflammatory responseSodium channel protein type 9 subunit alphaHomo sapiens (human)
circadian rhythmSodium channel protein type 9 subunit alphaHomo sapiens (human)
response to toxic substanceSodium channel protein type 9 subunit alphaHomo sapiens (human)
post-embryonic developmentSodium channel protein type 9 subunit alphaHomo sapiens (human)
sensory perception of painSodium channel protein type 9 subunit alphaHomo sapiens (human)
sodium ion transmembrane transportSodium channel protein type 9 subunit alphaHomo sapiens (human)
behavioral response to painSodium channel protein type 9 subunit alphaHomo sapiens (human)
detection of temperature stimulus involved in sensory perception of painSodium channel protein type 9 subunit alphaHomo sapiens (human)
detection of mechanical stimulus involved in sensory perceptionSodium channel protein type 9 subunit alphaHomo sapiens (human)
cardiac muscle cell action potential involved in contractionSodium channel protein type 9 subunit alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (22)

Processvia Protein(s)Taxonomy
voltage-gated sodium channel activitySodium channel protein type 1 subunit alphaHomo sapiens (human)
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialSodium channel protein type 1 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 4 subunit alphaHomo sapiens (human)
protein bindingSodium channel protein type 4 subunit alphaHomo sapiens (human)
sodium channel activitySodium channel protein type 7 subunit alphaHomo sapiens (human)
transmembrane transporter bindingSodium channel protein type 7 subunit alphaHomo sapiens (human)
osmolarity-sensing monoatomic cation channel activitySodium channel protein type 7 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 7 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 5 subunit alphaHomo sapiens (human)
protein bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
calmodulin bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
fibroblast growth factor bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
enzyme bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
protein kinase bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
protein domain specific bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
ankyrin bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
ubiquitin protein ligase bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
transmembrane transporter bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
nitric-oxide synthase bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activity involved in cardiac muscle cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activity involved in AV node cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activity involved in bundle of His cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activity involved in Purkinje myocyte action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activity involved in SA node cell action potentialSodium channel protein type 5 subunit alphaHomo sapiens (human)
scaffold protein bindingSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 9 subunit alphaHomo sapiens (human)
protein bindingSodium channel protein type 9 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 2 subunit alphaHomo sapiens (human)
protein bindingSodium channel protein type 2 subunit alphaHomo sapiens (human)
calmodulin bindingSodium channel protein type 2 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 3 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 11 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 8 subunit alphaHomo sapiens (human)
protein bindingSodium channel protein type 8 subunit alphaHomo sapiens (human)
ATP bindingSodium channel protein type 8 subunit alphaHomo sapiens (human)
sodium ion bindingSodium channel protein type 8 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 10 subunit alphaHomo sapiens (human)
transmembrane transporter bindingSodium channel protein type 10 subunit alphaHomo sapiens (human)
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialSodium channel protein type 10 subunit alphaHomo sapiens (human)
voltage-gated sodium channel activitySodium channel protein type 9 subunit alphaHomo sapiens (human)
protein bindingSodium channel protein type 9 subunit alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (33)

Processvia Protein(s)Taxonomy
plasma membraneSodium channel protein type 1 subunit alphaHomo sapiens (human)
nucleoplasmSodium channel protein type 1 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 1 subunit alphaHomo sapiens (human)
intercalated discSodium channel protein type 1 subunit alphaHomo sapiens (human)
nuclear bodySodium channel protein type 1 subunit alphaHomo sapiens (human)
Z discSodium channel protein type 1 subunit alphaHomo sapiens (human)
T-tubuleSodium channel protein type 1 subunit alphaHomo sapiens (human)
node of RanvierSodium channel protein type 1 subunit alphaHomo sapiens (human)
neuronal cell bodySodium channel protein type 1 subunit alphaHomo sapiens (human)
axon initial segmentSodium channel protein type 1 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 1 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 4 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 4 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 7 subunit alphaHomo sapiens (human)
glial cell projectionSodium channel protein type 7 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 7 subunit alphaHomo sapiens (human)
caveolaSodium channel protein type 5 subunit alphaHomo sapiens (human)
nucleoplasmSodium channel protein type 5 subunit alphaHomo sapiens (human)
nucleolusSodium channel protein type 5 subunit alphaHomo sapiens (human)
endoplasmic reticulumSodium channel protein type 5 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 5 subunit alphaHomo sapiens (human)
caveolaSodium channel protein type 5 subunit alphaHomo sapiens (human)
cell surfaceSodium channel protein type 5 subunit alphaHomo sapiens (human)
intercalated discSodium channel protein type 5 subunit alphaHomo sapiens (human)
membraneSodium channel protein type 5 subunit alphaHomo sapiens (human)
lateral plasma membraneSodium channel protein type 5 subunit alphaHomo sapiens (human)
Z discSodium channel protein type 5 subunit alphaHomo sapiens (human)
T-tubuleSodium channel protein type 5 subunit alphaHomo sapiens (human)
sarcolemmaSodium channel protein type 5 subunit alphaHomo sapiens (human)
perinuclear region of cytoplasmSodium channel protein type 5 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 5 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 9 subunit alphaHomo sapiens (human)
axonSodium channel protein type 9 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 9 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 2 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 2 subunit alphaHomo sapiens (human)
intercalated discSodium channel protein type 2 subunit alphaHomo sapiens (human)
T-tubuleSodium channel protein type 2 subunit alphaHomo sapiens (human)
axonSodium channel protein type 2 subunit alphaHomo sapiens (human)
node of RanvierSodium channel protein type 2 subunit alphaHomo sapiens (human)
paranode region of axonSodium channel protein type 2 subunit alphaHomo sapiens (human)
presynaptic membraneSodium channel protein type 2 subunit alphaHomo sapiens (human)
glutamatergic synapseSodium channel protein type 2 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 2 subunit alphaHomo sapiens (human)
membraneSodium channel protein type 2 subunit alphaHomo sapiens (human)
sarcoplasmSodium channel protein type 3 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 3 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 11 subunit alphaHomo sapiens (human)
axonSodium channel protein type 11 subunit alphaHomo sapiens (human)
neuronal cell bodySodium channel protein type 11 subunit alphaHomo sapiens (human)
axonal growth coneSodium channel protein type 11 subunit alphaHomo sapiens (human)
C-fiberSodium channel protein type 11 subunit alphaHomo sapiens (human)
extracellular exosomeSodium channel protein type 11 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 11 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 8 subunit alphaHomo sapiens (human)
membraneSodium channel protein type 8 subunit alphaHomo sapiens (human)
Z discSodium channel protein type 8 subunit alphaHomo sapiens (human)
cell junctionSodium channel protein type 8 subunit alphaHomo sapiens (human)
axonSodium channel protein type 8 subunit alphaHomo sapiens (human)
cytoplasmic vesicleSodium channel protein type 8 subunit alphaHomo sapiens (human)
node of RanvierSodium channel protein type 8 subunit alphaHomo sapiens (human)
axon initial segmentSodium channel protein type 8 subunit alphaHomo sapiens (human)
presynaptic active zone membraneSodium channel protein type 8 subunit alphaHomo sapiens (human)
parallel fiber to Purkinje cell synapseSodium channel protein type 8 subunit alphaHomo sapiens (human)
postsynaptic density membraneSodium channel protein type 8 subunit alphaHomo sapiens (human)
glutamatergic synapseSodium channel protein type 8 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 8 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 10 subunit alphaHomo sapiens (human)
axonSodium channel protein type 10 subunit alphaHomo sapiens (human)
presynaptic membraneSodium channel protein type 10 subunit alphaHomo sapiens (human)
extracellular exosomeSodium channel protein type 10 subunit alphaHomo sapiens (human)
glutamatergic synapseSodium channel protein type 10 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 10 subunit alphaHomo sapiens (human)
clathrin complexSodium channel protein type 10 subunit alphaHomo sapiens (human)
plasma membraneSodium channel protein type 9 subunit alphaHomo sapiens (human)
axonSodium channel protein type 9 subunit alphaHomo sapiens (human)
voltage-gated sodium channel complexSodium channel protein type 9 subunit alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (99)

Assay IDTitleYearJournalArticle
AID406936Inhibition of global ischemia-induced diastolic contracture in isolated Langendorff perfused guinea pig model heart at 1 uM after 15 mins2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Sodium late current blockers in ischemia reperfusion: is the bullet magic?
AID726291Inhibition of voltage-gated Na channel 1.3 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1277326Neuroprotective activity against veratradine-induced neuronal cell death in bovine chromaffin cells assessed as cell viability at 1 uM after 24 hrs by LDH release assay relative to control2016European journal of medicinal chemistry, Feb-15, Volume: 109Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na(+)/Ca(2+) exchanger.
AID1656806Antimigratory activity against human A549 cells assessed as reduction in cell migration at 10 uM measured after 24 hrs by scratch wound healing assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1432158Antagonist activity at human Nav1.2 expressed in HEK293T cells assessed as inhibition of VTD-induced peak current by measuring peak current at 30 nM by whole cell patch clamp method (Rvb = 82 +/- 5.1%)2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID1594737Displacement of [3H]saxitoxin from NaV in rat brain membranes2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation and Biological Activity of 8- Epitetrodotoxin and the Structure of a Possible Biosynthetic Shunt Product of Tetrodotoxin, Cep-226A, from the Newt Cynops ensicauda popei.
AID1129298Neuroprotective activity in oxygen/glucose deprivation-induced Wistar rat hippocampal slice assessed as inhibition of cell death by measuring ATP level at 1 uM2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
AID726286Inhibition of voltage-gated Na channel 1.8 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1525397Selectivity index, ratio of IC50 for inhibition of human Nav1.3 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1594735Inhibition of NaV in mouse Neuro2a cells assessed as suppression of ouabain/veratridine-induced reduction in cell viability measured after 20 hrs by WST8 assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation and Biological Activity of 8- Epitetrodotoxin and the Structure of a Possible Biosynthetic Shunt Product of Tetrodotoxin, Cep-226A, from the Newt Cynops ensicauda popei.
AID1525396Selectivity index, ratio of IC50 for inhibition of human Nav1.2 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1656807Antimigratory activity against human H460 cells assessed as reduction in cell migration at 10 uM measured after 24 hrs by scratch wound healing assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1525390Inhibition of human Nav1.3 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1525393Inhibition of human Nav1.6 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1887114Toxicity in ddY mouse assessed as animal death at 200 ng, IP and measured after 18.6 mins2022Journal of natural products, 09-23, Volume: 85, Issue:9
Isolation and Biological Activity of 9-
AID1125602Inhibition of Nav in mouse Neuro-2a cells assessed as inhibition of ouabain and veratridine-induced cytotoxicity after 24 hrs by WST-8 assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Isolation of 6-deoxytetrodotoxin from the pufferfish, Takifugu pardalis, and a comparison of the effects of the C-6 and C-11 hydroxy groups of tetrodotoxin on its activity.
AID420741Inhibition of human Nav1.5 channel expressed in HEK293 cells assessed as blockade of veratridine-induced late inward sodium current elicited at -30 mV from holding potential -110 mV at 10 uM by patch clamp method2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Na+ currents in cardioprotection: better to be late.
AID726284Inhibition of voltage-gated Na channel 1.9 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1525395Selectivity index, ratio of IC50 for inhibition of human Nav1.1 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1525394Inhibition of human Nav1.8 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1525392Inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1656797Cytotoxicity against human A549 cells assessed as effect on cell viability at 10 to 30 uM measured after 24 hrs by MTT assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID599097Inhibition of human NaV1.7 expressed in HEK293 cells by [14C]guanidinium influx assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain.
AID1656801Cytotoxicity against human A549 cells assessed as reduction in cell viability at 30 uM measured after 24 hrs by MTT assay relative to control2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1525450Analgesic activity in sc dosed rat model of SNL-induced pain2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1278103Inhibition of 5-HT-induced contraction in Sprague-Dawley rat ileum at 0.3 uM incubated for 10 mins2016European journal of medicinal chemistry, Mar-03, Volume: 110Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus.
AID1432160Antagonist activity at human Nav1.2 expressed in HEK293T cells assessed as inhibition of VTD-induced tail current by measuring tail current at 30 nM at holding potential of -100mV by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID726292Inhibition of voltage-gated Na channel 1.1 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1656809Induction of cell migration in human A549 cells at 30 uM measured after 24 hrs by scratch wound healing assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1525388Inhibition of human Nav1.1 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1525398Selectivity index, ratio of IC50 for inhibition of human Nav1.4 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID420742Inhibition of human Nav1.5 channel expressed in HEK293 cells assessed as blockade of veratridine-induced late inward sodium current elicited at -30 mV from holding potential -90 mV at 10 uM by patch clamp method2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Na+ currents in cardioprotection: better to be late.
AID420743Cardioprotective activity in Wistar rat atrium assessed as inhibition of veratridine-induced diastolic contracture at 1 uM administered 15 mins before veratridine challenge2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Na+ currents in cardioprotection: better to be late.
AID1635769Neuroprotective activity in rat cortical motor neurons assessed as reversal of veratridine-induced cytotoxicity at 1 uM preincubated for 24 hrs followed by coincubation with veratridine for 24 hrs by MTT assay2016Journal of medicinal chemistry, 07-14, Volume: 59, Issue:13
Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.
AID1525391Inhibition of human Nav1.4 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1392261Anti-invasive activity against human MDA-MB-231 cells at 30 uM after 24 hrs by Hema staining based microscopic method relative to control2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery and evaluation of nNa
AID1525399Selectivity index, ratio of IC50 for inhibition of human Nav1.5 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1525401Selectivity index, ratio of IC50 for inhibition of human Nav1.8 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1656802Cytotoxicity against human H460 cells assessed as reduction in cell viability at 30 uM measured after 24 hrs by MTT assay relative to control2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1105312Inhibition of Nav channel in Periplaneta americana (American cockroach) DUM neurons at 300 nM measured at holding potential -90 mV depolarized to -10 mV after 10 min by whole cell patch clamp assay relative to control2011Molecular pharmacology, Jul, Volume: 80, Issue:1
A novel family of insect-selective peptide neurotoxins targeting insect large-conductance calcium-activated K+ channels isolated from the venom of the theraphosid spider Eucratoscelus constrictus.
AID1656810Induction of cell migration in human U87MG cells at 30 uM measured after 6 hrs by scratch wound healing assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1656815Antiinvasive activity against human U87MG cells assessed as reduction in cell invasion at 10 to 30 uM measured after 24 hrs using Diff-quick staining by light microscopy based Boyden chamber assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1432165Antagonist activity at human Nav1.6 expressed in HEK293T cells assessed as inhibition of VTD-induced sustained current at 30 nM by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID1432164Antagonist activity at human Nav1.6 expressed in HEK293T cells assessed as inhibition of VTD-induced peak current at 30 nM by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID406933Inhibition of human sodium Nav1.5 channel expressed in HEK293 cells assessed as inhibition of veratridine-induced late sodium current elicited at -30 mV from holding potential of -110 mV at 10 uM by patch clamp technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Sodium late current blockers in ischemia reperfusion: is the bullet magic?
AID1525389Inhibition of human Nav1.2 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1656798Cytotoxicity against human H460 cells assessed as effect on cell viability at 10 to 30 uM measured after 24 hrs by MTT assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID726287Inhibition of voltage-gated Na channel 1.5 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1432172Antagonist activity at human Nav1.7 expressed in HEK293T cells assessed as inhibition of VTD-induced tail current at 30 nM at holding potential of -100mV by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID1525400Selectivity index, ratio of IC50 for inhibition of human Nav1.6 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID406934Inhibition of human sodium Nav1.5 channel expressed in HEK293 cells assessed as inhibition of veratridine-induced late sodium current elicited at -30 mV from holding potential of -90 mV at 10 uM by patch clamp technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Sodium late current blockers in ischemia reperfusion: is the bullet magic?
AID1525447Selectivity index, ratio of IC50 for inhibition of human Nav1.9 expressed in HEK293 cells by electrophysiology assay to IC50 for inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1432159Antagonist activity at human Nav1.2 expressed in HEK293T cells assessed as inhibition of VTD-induced sustained current by measuring sustained current at 30 nM by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID205296In vitro inhibition of [14C]- guanidinium influx in Chinese hamster ovary (CHO) cells expressing rat brain sodium channel type IIA (CNaIIA-1)1998Journal of medicinal chemistry, Jul-30, Volume: 41, Issue:16
Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.
AID1656808Antimigratory activity against human U87MG cells assessed as reduction in cell migration at 10 uM measured after 6 hrs by scratch wound healing assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1525446Inhibition of human Nav1.9 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID420744Cardioprotective activity in Langendorff-perfused guinea pig heart assessed as inhibition of global ischemia-induced diastolic contracture at 1 uM2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Na+ currents in cardioprotection: better to be late.
AID1656816Antiinvasive activity against human A549 cells assessed as reduction in cell invasion at 10 to 30 uM measured after 24 hrs using Diff-quick staining by light microscopy based Boyden chamber assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID726288Inhibition of voltage-gated Na channel 1.6 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID406935Inhibition of veratridine-induced diastolic contracture in Wistar rat atrium assessed as inhibition of systolic isometric tension of at 1 uM 15 mins2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Sodium late current blockers in ischemia reperfusion: is the bullet magic?
AID1432166Antagonist activity at human Nav1.6 expressed in HEK293T cells assessed as inhibition of VTD-induced tail current at 30 nM at holding potential of -100mV by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID1594739Inhibition of NaV in frog skeletal muscle fiber assessed as blockade of sodium current measured after 10 mins by voltage-clamp method2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation and Biological Activity of 8- Epitetrodotoxin and the Structure of a Possible Biosynthetic Shunt Product of Tetrodotoxin, Cep-226A, from the Newt Cynops ensicauda popei.
AID1432156Antagonist activity at VSSC in mouse Neuro2a cells assessed as inhibition of peak current at holding potential of -100mV at 100 nM by patch-clamp method2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID1887115Toxicity in ddY mouse assessed as animal death at 250 ng, IP and measured at 9.5 min2022Journal of natural products, 09-23, Volume: 85, Issue:9
Isolation and Biological Activity of 9-
AID1392259Inhibition of neonatal Nav1.5 in human MDA-MB-231 cells assessed as reduction in inward sodium peak current at 30 uM at -100 mV holding potential after 5 to 10 mins by whole cell patch clamp method relative to control2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery and evaluation of nNa
AID1525449Analgesic activity in sc dosed rat model of pain by writhing test2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1392256Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 24 hrs by MTS assay2018Bioorganic & medicinal chemistry, 05-15, Volume: 26, Issue:9
Discovery and evaluation of nNa
AID146836Inhibition of Na+ influx in chinese hamster ovary cells expressing rat brain sodium channel type IIA1994Journal of medicinal chemistry, Jan-21, Volume: 37, Issue:2
Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.
AID1877744Neuroprotective activity in primary neocortical neuron (unknown origin) assessed as inhibition of 4-AP-induced spontaneous calcium channel oscillation amplitude measured after 15 min by Fluo-4AM dye based fluorescence assay2022Journal of natural products, 03-25, Volume: 85, Issue:3
Cadinane Sesquiterpenoids and Their Glycosides from
AID1877745Neuroprotective activity in primary neocortical neuron (unknown origin) assessed as inhibition of 4-AP-induced spontaneous calcium channel oscillation frequency measured after 15 min by Fluo-4AM dye based fluorescence assay2022Journal of natural products, 03-25, Volume: 85, Issue:3
Cadinane Sesquiterpenoids and Their Glycosides from
AID1525448Analgesic activity in sc dosed rat model of formalin-induced pain2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID1432170Antagonist activity at human Nav1.7 expressed in HEK293T cells assessed as inhibition of VTD-induced peak current at 30 nM by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID726290Inhibition of voltage-gated Na channel 1.2 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1594738Toxicity in ip dosed mouse2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation and Biological Activity of 8- Epitetrodotoxin and the Structure of a Possible Biosynthetic Shunt Product of Tetrodotoxin, Cep-226A, from the Newt Cynops ensicauda popei.
AID1656800Cytotoxicity against human U87MG cells assessed as effect on cell viability at 10 to 30 uM measured after 24 hrs by SRB assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1432171Antagonist activity at human Nav1.7 expressed in HEK293T cells assessed as inhibition of VTD-induced sustained current at 30 nM by whole cell patch clamp method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Inhibition of veratridine-induced delayed inactivation of the voltage-sensitive sodium channel by synthetic analogs of crambescin B.
AID383536Inhibition of electrical field stimulation-induced neurogenic contractions in New Zealand white rabbit gastric fundus smooth muscle2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Evaluation of myorelaxant activity of 7-substituted hexahydroquinoline derivatives in isolated rabbit gastric fundus.
AID726289Inhibition of voltage-gated Na channel 1.4 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1656799Cytotoxicity against human U87MG cells assessed as effect on cell viability at 10 to 30 uM measured after 24 hrs by MTT assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1656812Antiinvasive activity against human H460 cells assessed as reduction in cell invasion measured after 24 hrs using Diff-quick staining by light microscopy based Boyden chamber assay2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line.
AID1525384Inhibition of human Nav1.7 expressed in HEK293 cells by electrophysiology assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
AID726285Inhibition of voltage-gated Na channel 1.7 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Ion channels as therapeutic targets: a drug discovery perspective.
AID1346749Human Nav1.7 (Voltage-gated sodium channels)1995The EMBO journal, Mar-15, Volume: 14, Issue:6
Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells.
AID1346779Rat Nav1.7 (Voltage-gated sodium channels)1997The Journal of biological chemistry, Jun-06, Volume: 272, Issue:23
A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia.
AID1346772Rat Nav1.5 (Voltage-gated sodium channels)1996The American journal of physiology, May, Volume: 270, Issue:5 Pt 1
Cardiac sodium channels expressed in a peripheral neurotumor-derived cell line, RT4-B8.
AID1346787Human Nav1.3 (Voltage-gated sodium channels)2000The European journal of neuroscience, Dec, Volume: 12, Issue:12
Cloning, distribution and functional analysis of the type III sodium channel from human brain.
AID1346731Rat Nav1.2 (Voltage-gated sodium channels)2005Nature, Apr-07, Volume: 434, Issue:7034
Sodium channel mutation leading to saxitoxin resistance in clams increases risk of PSP.
AID1346750Mouse Nav1.6 (Voltage-gated sodium channels)1998The Journal of neuroscience : the official journal of the Society for Neuroscience, Aug-15, Volume: 18, Issue:16
Functional analysis of the mouse Scn8a sodium channel.
AID1346797Rat Nav1.6 (Voltage-gated sodium channels)1998Journal of neurochemistry, Jun, Volume: 70, Issue:6
Functional analysis of a voltage-gated sodium channel and its splice variant from rat dorsal root ganglia.
AID1346781Rat Nav1.4 (Voltage-gated sodium channels)1989Neuron, Jul, Volume: 3, Issue:1
Primary structure and functional expression of a mammalian skeletal muscle sodium channel.
AID1346760Rat Nav1.8 (Voltage-gated sodium channels)1996Nature, Jan-18, Volume: 379, Issue:6562
A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons.
AID1346772Rat Nav1.5 (Voltage-gated sodium channels)1990FEBS letters, Nov-26, Volume: 275, Issue:1-2
Functional expression of the rat heart I Na+ channel isoform. Demonstration of properties characteristic of native cardiac Na+ channels.
AID1346791Rat Nav1.1 (Voltage-gated sodium channels)1998The Journal of neuroscience : the official journal of the Society for Neuroscience, Feb-01, Volume: 18, Issue:3
Functional analysis of the rat I sodium channel in xenopus oocytes.
AID1346737Human Nav1.4 (Voltage-gated sodium channels)1994Pflugers Archiv : European journal of physiology, May, Volume: 427, Issue:1-2
Functional expression and properties of the human skeletal muscle sodium channel.
AID1346745Rat Nav1.9 (Voltage-gated sodium channels)1999The Journal of neuroscience : the official journal of the Society for Neuroscience, Dec-15, Volume: 19, Issue:24
A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons.
AID1365278Antagonist activity at 5-HT2A receptor in Sprague-Dawley rat ielum assessed as reduction in 5-HT-evoked contraction at 0.3 uM2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
New 5-HT
AID1420146Inhibition of Nav1.7 (unknown origin) by electrophysiology assay2018Bioorganic & medicinal chemistry letters, 10-15, Volume: 28, Issue:19
Na
AID1420160Toxicity in mouse assessed as mortality2018Bioorganic & medicinal chemistry letters, 10-15, Volume: 28, Issue:19
Na
AID1594735Inhibition of NaV in mouse Neuro2a cells assessed as suppression of ouabain/veratridine-induced reduction in cell viability measured after 20 hrs by WST8 assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation and Biological Activity of 8- Epitetrodotoxin and the Structure of a Possible Biosynthetic Shunt Product of Tetrodotoxin, Cep-226A, from the Newt Cynops ensicauda popei.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12,732)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904512 (35.44)18.7374
1990's3730 (29.30)18.2507
2000's2809 (22.06)29.6817
2010's1446 (11.36)24.3611
2020's235 (1.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 71.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index71.04 (24.57)
Research Supply Index9.47 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index130.95 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (71.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials11 (0.08%)5.53%
Reviews2 (10.00%)6.00%
Reviews252 (1.94%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies75 (0.58%)4.05%
Observational0 (0.00%)0.25%
Observational1 (0.01%)0.25%
Other18 (90.00%)84.16%
Other12,653 (97.39%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain [NCT05359133]Phase 2222 participants (Anticipated)Interventional2022-04-19Recruiting
A Multicentre, Open-label, Long-term Efficacy and Safety Continuation Study of Subcutaneous Tetrodotoxin (TTX) for Moderate to Severe Cancer-related Pain [NCT00726011]Phase 3113 participants (Actual)Interventional2008-07-31Completed
A Multicentre , Randomized, Double-blind, Placebo-controlled, Parallel-design Trial of the Efficacy and Safety of Subcutaneous Tetrodotoxin (TTX) for Moderate to Severe Inadequately Controlled Cancer-related Pain [NCT00725114]Phase 3165 participants (Actual)Interventional2008-04-30Completed
A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects [NCT04083833]Phase 125 participants (Actual)Interventional2018-02-07Completed
COMPARISON OF THE PHARMACOKINETICS AND SAFETY OF LIQUID (30 µg) AND LYOPHILIZED TETRODOTOXIN (15 µg AND 30 µg) FOLLOWING SINGLE AND TWICE DAILY SUBCUTANEOUS DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS-DETERMINATIONS IN BLOOD AND URINE [NCT01527734]Phase 144 participants (Actual)Interventional2011-12-31Completed
A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Phase II Multicenter Study of Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain [NCT01655823]Phase 2125 participants (Actual)Interventional2012-07-31Terminated(stopped due to Interim analysis completed and decided to terminate and proceed to Phase 3 trial.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT01655823 (1) [back to overview]Change From Baseline in Patient Reported Outcome for Pain at Day 22 to Day 28.

Change From Baseline in Patient Reported Outcome for Pain at Day 22 to Day 28.

The primary efficacy endpoint for Part I was the change from baseline in weekly average NPRS scores at 22 to 28 days after treatment. Baseline was defined as the average of NPRS scores for the last 7 days prior to dosing. Pain was assessed using a Numerical Pain Rating Scale (NPRS) with a range of 0 (no pain) to 10 (extreme pain). (NCT01655823)
Timeframe: Day 22 to Day 28

,,,,
Intervention11 point units on a scale (Mean)
BaselineMean Scores for Days 22-28Change from Baseline in Mean Scores for Days 22-28
Low Dose Tetrodotoxin (Twice Daily)6.2855.005-1.269
Max Dose Tetrodotoxin (Once Daily)6.2404.566-1.682
Max Dose Tetrodotoxin (Twice Daily)6.2554.749-1.529
Mid-range Dose of Tetrodotoxin (Twice Daily)7.0125.987-1.052
Placebo (Twice Daily)6.6625.323-1.339

[back to top]